{"Title": ["Ex-Dividend Reminder: Wingstop, Aaron's and Luminex", "Wall St Week Ahead-Investors look beyond drug makers as hunt for Covid-19 treatment heats up", "Wall St Week Ahead-Investors look beyond drug makers as hunt for Covid-19 treatment heats up", "Wall St Week Ahead-Investors look beyond drug makers as hunt for Covid-19 treatment heats up", "Interesting LMNX Put And Call Options For January 2021", "Why Luminex Shares Are Tumbling 13.5% Today", "BUZZ-U.S. STOCKS ON THE MOVE-Banks, Boeing, Uber, Disney", "Luminex Corp (DE) (LMNX) Q1 2020 Earnings Call Transcript", "Ex-Dividend Reminder: Wingstop, Aaron's and Luminex", "Strategy To YieldBoost LMNX From 1.5% To 15% Using Options", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for December 18, 2019", "3 Cheap Dividend Stocks Trading Near Their 52-Week Lows", "Monday 11/11 Insider Buying Report: LILA, LMNX", "Luminex Corp (DE) (LMNX) Q3 2019 Earnings Call Transcript", "Cash Dividend On The Way From Luminex (LMNX)", "Insiders Were Right: LMNX Makes New 52-Week High", "Luminex Corp (DE) (LMNX) Q4 2019 Earnings Call Transcript", "Strategy To YieldBoost LMNX From 1.5% To 15% Using Options", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for December 18, 2019", "3 Cheap Dividend Stocks Trading Near Their 52-Week Lows", "Monday 11/11 Insider Buying Report: LILA, LMNX", "Luminex Corp (DE) (LMNX) Q3 2019 Earnings Call Transcript", "Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster", "Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript", "Notable Monday Option Activity: LMNX, DPZ, MMM", "Commit To Purchase Luminex Corp At $22.50, Earn 16.9% Annualized Using Options", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for March 20, 2019", "Luminex (LMNX) Down 2.7% Since Last Earnings Report: Can It Rebound?", "Luminex Hurt By Segmental Sluggishness, Stiff Competition", "Noteworthy Friday Option Activity: LNG, LMNX, IBM", "Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster", "Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript", "Notable Monday Option Activity: LMNX, DPZ, MMM", "Commit To Purchase Luminex Corp At $22.50, Earn 16.9% Annualized Using Options", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for March 20, 2019", "Luminex (LMNX) Down 2.7% Since Last Earnings Report: Can It Rebound?", "Luminex Hurt By Segmental Sluggishness, Stiff Competition", "Noteworthy Friday Option Activity: LNG, LMNX, IBM", "Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster", "Luminex Corp (DE) (LMNX) Q2 2019 Earnings Call Transcript", "Notable Monday Option Activity: LMNX, DPZ, MMM", "Commit To Purchase Luminex Corp At $22.50, Earn 16.9% Annualized Using Options", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for March 20, 2019", "Luminex (LMNX) Down 2.7% Since Last Earnings Report: Can It Rebound?", "Luminex Hurt By Segmental Sluggishness, Stiff Competition", "Noteworthy Friday Option Activity: LNG, LMNX, IBM", "LMNX or PACB: Which is a Better MedTech Investment Pick?", "Luminex Corp (LMNX) Q4 2018 Earnings Conference Call Transcript", "Luminex (LMNX) Q4 Earnings Miss Estimates", "Earnings Reaction History: Luminex Corporation, 50.0% Follow-Through Indicator, 8.6% Sensitive", "Bullish Two Hundred Day Moving Average Cross - LMNX", "Earnings Preview: Luminex (LMNX) Q4 Earnings Expected to Decline", "Luminex's (LMNX) Preliminary Q4 Results Cheer Investors", "Here's Why Investors Should Hold Luminex (LMNX) Stock Now", "LMNX or PACB: Which is a Better MedTech Investment Pick?", "Luminex Corp (LMNX) Q4 2018 Earnings Conference Call Transcript", "Luminex (LMNX) Q4 Earnings Miss Estimates", "Earnings Reaction History: Luminex Corporation, 50.0% Follow-Through Indicator, 8.6% Sensitive", "Bullish Two Hundred Day Moving Average Cross - LMNX", "Earnings Preview: Luminex (LMNX) Q4 Earnings Expected to Decline", "Luminex's (LMNX) Preliminary Q4 Results Cheer Investors", "Here's Why Investors Should Hold Luminex (LMNX) Stock Now", "LMNX or PACB: Which is a Better MedTech Investment Pick?", "Luminex Corp (LMNX) Q4 2018 Earnings Conference Call Transcript", "Ex-Dividend Reminder: Luminex, QTS Realty Trust and Chubb", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for December 19, 2018", "Why Is Luminex (LMNX) Up 12.4% Since Last Earnings Report?", "Luminex's (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Breaks Below 200-Day Moving Average - Notable for LMNX", "Luminex Corporation (LMNX) Q3 Earnings Conference Call Transcript", "Luminex (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M", "Ex-Dividend Reminder: Luminex, QTS Realty Trust and Chubb", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for December 19, 2018", "Why Is Luminex (LMNX) Up 12.4% Since Last Earnings Report?", "Luminex's (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Breaks Below 200-Day Moving Average - Notable for LMNX", "Luminex Corporation (LMNX) Q3 Earnings Conference Call Transcript", "Luminex (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M", "Ex-Dividend Reminder: Luminex, QTS Realty Trust and Chubb", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for December 19, 2018", "Why Is Luminex (LMNX) Up 12.4% Since Last Earnings Report?", "Luminex's (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Breaks Below 200-Day Moving Average - Notable for LMNX", "Luminex Corporation (LMNX) Q3 Earnings Conference Call Transcript", "Luminex (LMNX) Q3 Earnings and Revenues Miss Estimates", "Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M", "Will Advance Medical Buyout Aid Teladoc (TDOC) Q3 Earnings?", "Can CAG Growth Steadily Drive IDEXX (IDXX) in Q3 Earnings?", "Will Robust ICL Sales Aid STAAR Surgical (STAA) Q3 Earnings?", "Will Amedisys' (AMED) Q3 Earnings Reflect Overall Gain?", "What's in Store for Medpace Holdings (MEDP) in Q3 Earnings?", "Will Global Industrial Unit Boost Ecolab's (ECL) Q3 Earnings?", "Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus", "Luminex (LMNX) Q3 Earnings Preview: What to Expect", "Will Advance Medical Buyout Aid Teladoc (TDOC) Q3 Earnings?", "Can CAG Growth Steadily Drive IDEXX (IDXX) in Q3 Earnings?", "Will Robust ICL Sales Aid STAAR Surgical (STAA) Q3 Earnings?", "Will Amedisys' (AMED) Q3 Earnings Reflect Overall Gain?", "What's in Store for Medpace Holdings (MEDP) in Q3 Earnings?", "Will Global Industrial Unit Boost Ecolab's (ECL) Q3 Earnings?", "Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus", "Luminex (LMNX) Q3 Earnings Preview: What to Expect", "Will Advance Medical Buyout Aid Teladoc (TDOC) Q3 Earnings?", "Can CAG Growth Steadily Drive IDEXX (IDXX) in Q3 Earnings?", "Will Robust ICL Sales Aid STAAR Surgical (STAA) Q3 Earnings?", "Will Amedisys' (AMED) Q3 Earnings Reflect Overall Gain?", "What's in Store for Medpace Holdings (MEDP) in Q3 Earnings?", "Will Global Industrial Unit Boost Ecolab's (ECL) Q3 Earnings?", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for September 20, 2018", "Why Is Luminex (LMNX) Up 15% Since Last Earnings Report?", "ITGR or LMNX: Which Is the Better Value Stock Right Now?", "Validea Peter Lynch Strategy Daily Upgrade Report - 8/8/2018", "Luminex (LMNX) Misses on Earnings in Q2, Margins Contract", "Mid-Afternoon Market Update: Commercial Vehicle Group Rises On Earnings Beat; Luminex Shares Slide", "Medical Product Stock Earnings on Aug 6: CAH, HSIC & More", "Luminex (LMNX) Looks Good: Stock Adds 5.7% in Session", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for September 20, 2018", "Luminex (LMNX) Beats Q1 Estimates on ARIES Platform Strength", "Luminex (LMNX) Product Portfolio Solid, Competition Rife", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for March 22, 2018", "Why Is Luminex (LMNX) Up 11.2% Since Its Last Earnings Report?", "Validea Peter Lynch Strategy Daily Upgrade Report - 3/6/2018", "Luminex (LMNX) Banks on Solid Product Line, Competition Rife", "Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for June 21, 2018", "DexCom (DXCM) Banks on Collaborations, Competition Rife", "NuVasive (NUVA) Global Prospects Solid, Pricing Woes Remain", "Innovation, Partnership Aid Genomic Health, Cost Woe Remains", "TransEnterix & GBIL Ink Deal to Commercialize SurgiBot System", "Amedisys (AMED) Banks on Personal Care Amid Margin Woes", "Ecolab, Cargill and Techstars Launch Accelerator Program", "Express Scripts Buys eviCore for $3.6B, Forays Into MBM", "PerkinElmer (PKI) Closes EUROIMMUN Acquisition for $1.3B", "DexCom (DXCM) Banks on Collaborations, Competition Rife", "NuVasive (NUVA) Global Prospects Solid, Pricing Woes Remain", "Innovation, Partnership Aid Genomic Health, Cost Woe Remains", "TransEnterix & GBIL Ink Deal to Commercialize SurgiBot System", "Amedisys (AMED) Banks on Personal Care Amid Margin Woes", "Ecolab, Cargill and Techstars Launch Accelerator Program", "Express Scripts Buys eviCore for $3.6B, Forays Into MBM", "PerkinElmer (PKI) Closes EUROIMMUN Acquisition for $1.3B", "BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo", "Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million", "Here's Why You Should Invest in Illumina (ILMN) Stock Now", "Myriad Genetics Rides on Solid Molecular Diagnostics Suite", "Cooper Companies (COO) Tops Q4 Earnings & Revenue Estimates", "Genomic Health-Janssen Pharma Tie Up, GPS Test in Focus", "Here's Why You Should Add Amedisys (AMED) to Your Portfolio", "Edwards Lifesciences' Pipeline Strong Amid Rising Expenses", "Varian's Partners Penn Medicine, Proton Therapy in Focus", "Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market", "Genomic Health-Cleveland Diagnostics Deal to Boost Test Suite", "GNC Holdings Grapples With Margin Weakness, Stiff Competition", "Stryker Gains Ground on MAKO Robotic Unit Amid Forex Woes", "LabCorp's Covance Business Bounces Back on Chiltern Buyout", "Align Technology (ALGN) Grows on InvisAlign System Strength", "Here's Why You Should Invest in Baxter (BAX) Stock Right Now", "Here's Why You Should Invest in Align Technology (ALGN) Now", "Medtronic (MDT) Beats on Q2 Earnings, Reiterates FY18 View", "Patterson Companies (PDCO) Misses on Q2 Earnings, Cuts View", "Five Scorching Hot Strong Buy Stocks", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Here's Why Investors Should Buy Myriad Genetics Right Now", "Myriad Genetics' Latest Alliance to Boost GeneSight Reach", "Luminex (LMNX) at 52-Week High: What's Driving the Stock?", "Here's Why Investors Should Buy Luminex (LMNX) Right Now", "Quest Diagnostics, Clinical Genomics Ally, Oncology Strong", "Weight Watchers (WTW) to Issue $500M Senior Notes Due 2025", "SurModics (SRDX) Posts Earnings in Q4, Revenues Top Estimates", "Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife", "Haemonetics (HAE) Q2 Earnings Beat Estimates, EPS View Up", "VWR Q3 Earnings Top, Sell-Off to Avantor Approaching Closure", "Hill-Rom (HRC) Banks on Product Launches, Competition Rife", "Hill-Rom (HRC) Q4 Earnings and Revenues Top, Margins Up", "CVS Health (CVS) Beats Q3 Earnings Estimates, Updates View", "Henry Schein (HSIC) Misses Q3 Earnings, Margins Decline", "CONMED (CNMD) Q3 Earnings and Revenues Beat, Margin Down", "BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Miss", "Bruker (BRKR) Q3 Earnings & Revenues Beat Estimates, View Up", "Allscripts (MDRX) Q3 Earnings Meet, Revenues Beat Estimates", "McKesson (MCK) to Acquire RxCrossroads for $735 Million", "DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q3", "Align Technology (ALGN) Gains on InvisAlign, Competition Rife", "Masimo (MASI) Beats on Q3 Earnings and Revenues, Raises View", "Abiomed (ABMD) Looks Good: Stock Adds 7.5% in Session", "Luminex (LMNX) Tops Q3 Earnings, Meets Revenue Estimates", "Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up", "Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues", "athenahealth (ATHN) Beats Earnings, Misses Revenues in Q3", "Here's Why Investors Should Sell Patterson Companies Now", "Here's Why Investors Should Sell Ecolab (ECL) Right Away", "OPKO Health (OPK) Signs New Agreement with Japan Tobacco", "PerkinElmer Hits a 52-Week High: What's Driving the Stock?", "Masimo (MASI) Launches Trace Data and Reporting Tool in US", "Genomic Health's Cost Pressure Mounts, Cancer Tests Strong", "Integra Rides High on Product Launches, Competition Rife", "Teleflex (TFX) Hits a 52-Week High on NeoTract Acquisition", "Hill-Rom (HRC) Rides on Product Launches, Competition Rife", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Alcoa, Cheesecake Factory, Luminex, Ligand Pharmaceuticals and Centene highlighted as Zacks Bull and Bear of the Day", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for September 21, 2017", "3 Healthcare Stocks to Buy on Renewed Obamacare Repeal Talks", "Here's Why Investors Should Buy Luminex (LMNX) Right Now", "Quest Diagnostics Buys 2 Outreach Labs, Widens Customer Base", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Luminex (LMNX) Beats Earnings & Revenue Estimates in Q2", "DENTSPLY SIRONA Renews Canadian Distribution Agreement", "Luminex Gets CE Mark for ARIES Norovirus Assay, Shares Rally", "CryoLife Hits a 52-Week High: What's Driving the Stock?", "Express Scripts Gains from Increased Generic Utilization", "Luminex (LMNX) Down 2.5% Since Earnings Report: Can It Rebound?", "Luminex Partners Sutter Health to Boost Molecular Testing", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Luminex (LMNX) Beats Earnings & Revenue Estimates in Q2", "DENTSPLY SIRONA Renews Canadian Distribution Agreement", "Luminex Gets CE Mark for ARIES Norovirus Assay, Shares Rally", "CryoLife Hits a 52-Week High: What's Driving the Stock?", "Express Scripts Gains from Increased Generic Utilization", "Luminex (LMNX) Down 2.5% Since Earnings Report: Can It Rebound?", "What Drove Becton, Dickinson (BDX) to a New 52-Week High?", "Quintiles' (Q) OCE Software to Simplify Commercial Functions", "Medidata (MDSO), inVentiv Enter Into Multi-Year Partnership", "Zacks.com featured highlights: RCI Hospitality Holdings, H&R Block, Sturm, Ruger & Company, Luminex and MarketAxess Holdings", "ConforMIS (CFMS) Gets FDA Approval for iTotal Hip System", "Merit Medical Embosphere Gets FDA de novo Classification", "Want to Combat Market Volatility? Buy 5 Low Beta Stocks", "Varian Rides on Oncology and Proton Therapy Businesses", "PRA Health Hits a 52-Week High on Strategic Acquisitions", "Luminex (LMNX) Banks on Portfolio Strength, View Impressive", "Medidata Solutions (MDSO) Set to Join the S&P 400 Index", "Luminex (LMNX) Scores a Strong Buy Right Now: Here's How", "PRA Health (PRAH) Shares Rally on Partnership with Jumo", "Neogen Offers NeoSeek Genomic Services to Ensure Food Safety", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for June 21, 2017", "Evolent Health (EVH) Prices 4.5M Follow-On Share Offering", "DENTSPLY (XRAY) Renews Partnership with Pacific Dental", "Pacific Biosciences (PACB) Prices Offering of Common Stock", "Varian Showcases Halcyon System at DEGRO Meet, Stock Up", "TransEnterix Sells Surgery System to Japanese University", "Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line", "CONMED (CNMD) Hits a 52-Week High: What's Driving the Stock?", "Luminex's (LMNX) VERIGENE Panels Receive Approval in Japan", "Ex-Dividend Reminder: Luminex, Zimmer Biomet Holdings and Pembina Pipeline", "Align Sets Up Manufacturing Center in China, Grows in APAC", "Inogen Secures New Direct-to-Consumer Business Facility", "RTI Surgical Now Part of US-Based Manufacturing Initiative", "Mead Johnson's Shareholders Approve Reckitt Benckiser Deal", "Hill-Rom Holdings Hits 52-Week High on Solid Product Line", "The Cooper Companies (COO) Beats Earnings Estimates in Q2", "Edwards Lifesciences' TAVR & International Prospects Solid", "Cerner (CERN) to Develop Electronic Health Records System", "Align Sets Up Manufacturing Center in China, Grows in APAC", "Inogen Secures New Direct-to-Consumer Business Facility", "RTI Surgical Now Part of US-Based Manufacturing Initiative", "Mead Johnson's Shareholders Approve Reckitt Benckiser Deal", "Medtronic Starts PRODIGY Study on Respiratory Compromise", "Becton, Dickinson at 52-Week High: What's Driving the Stock?", "Baxter International at a 52-Week High on Solid Product Line", "Patterson Companies Grapples With Multiple Issues: Dump Now?", "Masimo (MASI) O3 Regional Oximetry Device Gets FDA Nod", "LabCorp Trades Down on Weak 2017 View, Reimbursement Woes", "Boston Scientific Trades Up on Strong Q1 amid Recall Issues", "IDEXX Laboratories Global Growth Solid amid Currency Woes", "Quintiles IMS Holdings (Q) to Repurchase 10.6M Common Share", "NuVasive Aims for Innovation, Global Growth amid Woes", "Inogen (INGN) Hits a 52-Week High on Solid Q1, Upbeat View", "Intuitive Surgical da Vinci X Surgical System Okayed by FDA", "Thermo Fisher on an Acquisition Spree, Competition Rife", "Myriad Genetics Gets Extended Coverage for Prolaris Test", "Patterson Companies (PDCO) Earnings Beat Estimates in Q4", "Veeva Systems (VEEV) Beats Q1 Earnings, Revenues Estimates", "Stryker (SYK) at 52-Week High: What's Driving the Stock?", "Quest Diagnostics Hits a 52-Week High on Solid Prospects", "Henry Schein (HSIC) Rides on Global Growth, Strategic Deals", "Varian Medical at a 52-Week High: What's Driving the Stock?", "Boston Scientific (BSX) BT Study on Asthma Results Positive", "Varian (VAR) ProBeam Proton Therapy System Now in Thailand", "Align Technology Rises with Invisalign, SmartTrack Patents", "Medtronic (MDT) Tops Q4 Earnings, Sales on Balanced Growth", "Bruker Corp (BRKR) at 52-Week High: What's Driving the Stock?", "Intuitive Surgical at 52-Week High: What's Driving the Stock?", "Quality Systems Professional Service a Drag, Competition Rife", "Envision (EVHC) Acquires Gwinnett Emergency Specialists", "Halyard Health (HYH) Expands CORGRIP System Product Line", "Hologic (HOLX) Poised on Balanced Growth Amid Currency Woes", "Avoid Market Volatility with 5 Low-Beta Stocks", "IDEXX Laboratories (IDXX) Raised to Buy on Solid Prospects", "Bruker Corp (BRKR) at 52-Week High: What's Driving the Stock?", "Intuitive Surgical at 52-Week High: What's Driving the Stock?", "Quality Systems Professional Service a Drag, Competition Rife", "Integra Lifesciences Hits 52-Week High on Product Launches", "McKesson (MCK) Beats Earnings Estimate in Q4, Revenues Miss", "Halyard Health-Sustainable Solutions Ink License Agreement", "Hill Rom Impresses with Q2 Results, Strategic Initiatives", "Mazor Robotics at a 52-Week High: What's Driving the Stock?", "Exactech (EXAC) Gets FDA Approval for ExactechGPS Application", "Boston Scientific's Symetis Buyout Boosts Structural Heart", "Quality Systems (QSII) Beats Q4 Earnings, Issues FY18 View", "Halyard Health Announces New Drainage System, Stock Down", "Boston Scientific Hits a 52-Week High on Solid Prospects", "Abbott Lab Well Poised on Strong EPD, St. Jude Integration", "Genomic Health Q1 Results Weak, Cancer Test Business Strong", "Evolent Health (EVH) Prices 7M Follow-On Share Offering", "Genomic Health's (GHDX) Oncotype DX GPS Test Data Positive", "Teleflex to Introduce Arrow AC3 Optimus at EuroPCR, Paris", "Medtronic's MyCareLink Data on Older Patients Found Positive", "Medtronic ICMs Detect High Rate of AF in Undiagnosed Patients", "CR Bard (BCR) Hits a 52-Week High: What's Driving the Stock?", "Varian ProBeam Proton System Gets Okayed by Shonin in Japan", "Luminex (LMNX) Tops Q1 Earnings, Revenue Guidance Raised", "Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher", "3 Top Medical Instrument Companies to Buy in 2017", "Luminex Corporation (LMNX) Ex-Dividend Date Scheduled for March 22, 2017", "Thermo Fisher (TMO) to Buy Patheon, Expand in Biopharma", "Luminex (LMNX) Posts Loss in Q4, Revenues Miss Estimates", "Should You Sell Luminex (LMNX) Before Earnings?", "Medical Product Stocks' Earnings on Feb 6: HAE, PAHC & More", "Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance", "Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay", "Luminex Awarded R&D 100 for ARIES Systems in November", "Luminex: Erasmus Assesses ARIES System, Flu A/B & RSV", "Luminex (LMNX) Down 4.4% Since Earnings Report: Can It Rebound?", "Medical Product Earnings Early Next Week: CAH, ZBH & More", "Should You Buy Luminex (LMNX) Ahead of Earnings?", "4 Medical Device Stocks on a Bull Run this Earnings Season", "Luminex Poised on Pipeline Strength, System Sales Upbeat", "Luminex (LMNX) Receives FDA Clearance for xMAP Assay", "Luminex (LMNX) Gets FDA Nod for Assays; Q2 Earnings Beat", "Luminex (LMNX) Rallies on FDA Nod for Aries M1 System", "Luminex (LMNX) Misses Q3 Earnings Estimates, '16 View Up", "Luminex Well Poised on Pipeline Strength, Strategic Tie-Ups", "Increased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher?", "Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked", "Midday Update: U.S. Stocks Treading Water Amid Fed Comments", "Mid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/Share", "Close Update: Stocks Trade Lower as Traders Eye Fed Clues on Rate Hikes", "Health Care Sector Update for 05/23/2016: NSPH,RNPT,CHRS", "Luminex Closes Nanosphere Buyout, Maintains FY16 View", "Luminex Well Poised on Pipeline Strength, Strategic Tie-Ups", "Increased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher?", "Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked", "Midday Update: U.S. Stocks Treading Water Amid Fed Comments", "Mid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/Share", "Close Update: Stocks Trade Lower as Traders Eye Fed Clues on Rate Hikes", "Health Care Sector Update for 05/23/2016: NSPH,RNPT,CHRS", "Luminex Closes Nanosphere Buyout, Maintains FY16 View", "Midday Update: Wall Street Buoyed by Gains in Apple and Oil", "Mid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop", "Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2B", "Varian Opens Service Center in Wuxi, Expands in China", "Luminex's (LMNX) ARIES Now CE-IVD Marked, Shares Fall", "Mazor Robotics Renaissance System Ordered in New Jersey", "Intuitive Surgical: FDA OKs da Vinci Xi Single-Site Instruments", "Luminex (LMNX) Beats Q1 Earnings & Revenues, Guides Up", "Intuitive Surgical: FDA Okays EndoWrist Stapler Instruments", "Inogen Q4 Earnings Crushes Estimates, FY16 View Impressive", "DexCom Launches G5 PLATINUM CGM App on Apple Watch", "Greatbatch Completes QiG Spin-Off; Nuvectra Begins Trading", "Cantel Medical Up on Q2 Earnings Beat, Sales Improvement", "Intuitive Surgical (ISRG) at 52-Week High on Solid Portfolio", "Inogen (INGN) Q4 Earnings: A Surprise in the Cards?", "Alere (ALR) Handed Subpoena by US DOJ; Shares Plunge", "Intuitive Surgical: FDA Okays EndoWrist Stapler Instruments", "Inogen Q4 Earnings Crushes Estimates, FY16 View Impressive", "DexCom Launches G5 PLATINUM CGM App on Apple Watch", "Greatbatch Completes QiG Spin-Off; Nuvectra Begins Trading", "Cantel Medical Up on Q2 Earnings Beat, Sales Improvement", "Intuitive Surgical (ISRG) at 52-Week High on Solid Portfolio", "Inogen (INGN) Q4 Earnings: A Surprise in the Cards?", "TrovaGene (TROV) Falls on Wider-than-Expected Q4 Loss", "Cooper Companies (COO) Beats on Q1 Earnings and Revenues", "Thermo Fisher (TMO) Tops Q4 Numbers Amid Currency Woes", "Weight Watchers Gains on Publicity Pact with Oprah Winfrey", "Natus Medical: NeuroQuest Buy Boosts In-home AEEG Suite", "Cantel Medical Acquisition Suite Accretive, Adds NAMSA Unit", "Akers Receives Order for Rapid Assays in China; Shares Rise", "TrovaGene (TROV) Inks Deal with Multiplan; Shares Rally", "Cogentix Medical Q3 Loss Narrower than Expected, Sales Top", "DENTSPLY & Sirona Dental Systems Unite, Form New Entity", "Evolent Q4 Loss Narrower than Expected, Revenues Beat", "PRA Health (PRAH) Q4 Earnings Top Estimates, Revenues Up", "Weight Watchers Posts Q4 Loss, Beats Revenue Estimate", "Fresenius Medical Misses on Q4 Earnings and Revenues", "Adeptus Health Q4 Earnings, Revenues Up Y/Y; Shares Rise", "Masimo (MASI) Misses Q4 Earnings, FY16 View Disappoints", "Nevro Q4 Loss Narrower than Expected; Revenues in Line", "Luminex Receives Regulatory Approval for ARIES in Canada", "TrovaGene (TROV) Up on Fortified Provider Network Deal", "Masimo's Specialized Root Monitoring Gets FDA Approval", "GNC Holdings: Overseas Business Strong, Competition Rife", "Mazor Robotics Q4 Loss Narrows, Revenues Improve Y/Y", "Stryker Eyes Physio-Control, Aims to Enhance Product Suite", "RTI Surgical (RTIX) Beats on Q4 Earnings and Revenues", "ICON (ICLR) Beats Q4 Earnings, Misses Revenue Estimates", "Align Technology: Invisalign Grows in Q4, Currency Bothers", "Qiagen Posts Positive Data for Next-Gen TB Diagnostic Assay", "CryoLife (CRY) Beats on Q4 Earnings; Revenues Up Y/Y", "Masimo's RAM Technology Proven to Reduce Alarm Events", "GNC Holdings Beats Q4 Earnings by a Penny; Hikes Dividend", "Invacare (IVC) Q4 Loss Narrower than Estimate, Sales Miss", "Henry Schein Rides High on Acquisitions amid Currency Woes", "Exactech (EXAC) Beats Q4 Earnings & Revenue Estimates", "Medidata (MDSO) Q4 Earnings Top, Revenues Miss, Up Y/Y", "Fluidigm Q4 Loss Narrower than Expected, Revenues Fall Y/Y", "Henry Schein (HSIC) Tops Q4 Earnings on Strong Revenues", "Cynosure (CYNO) Up on Q4 Earnings and Revenue Beat", "St. Jude Medical's OPTIS Mobile System in Japan & Europe", "STERIS Tops Q3 Earnings; Synergy Health Integration Strong", "AngioDynamics: Health Canada Okays Celerity with Navigation", "The Ensign Group Lags Q4 Earnings, Revenues; View Intact", "Luminex (LMNX) in Focus: Stock Adds 5.1% in Session", "Luminex (LMNX) Outshines Q4 Earnings, Revenues in Line", "Health Care Sector Update for 02/02/2016: LMNX,HNSN,CBYL", "Luminex (LMNX) Receives FDA Approval for NxTAG RPP", "Affymetrix (AFFX) Inks Partnership with Reveal Biosciences", "The Best Stocks in Gene Sequencing", "Can The Uptrend Continue for Luminex (LMNX)?", "Luminex (LMNX) Tops Q3 Earnings, Sales; Pipeline Strong", "Affymetrix Beats Q3 Earnings, Lags Sales, Margins View Up", "Luminex (LMNX) Signs Distribution Deal with Bio-Techne", "Luminex (LMNX) Shares Rally on FDA Approval for ARIES", "Luminex (LMNX) Tops Q2 Earnings, Revenues; Pipeline Strong - Analyst Blog", "Cepheid's (CPHD) Xpert HIV-1 Qual Test Gets CE-IVD Mark - Analyst Blog", "Qiagen Grows on Molecular Diagnostics, Americas Disappoint - Analyst Blog", "3 Big Healthcare Trends Wall Street Is Overlooking", "Luminex Commences Clinical Trials for ARIES GBS Assay - Analyst Blog", "Surging Earnings Estimates Signal Good News for Luminex (LMNX) - Tale of the Tape", "Luminex Tops Q1 Earnings, Revenues; Maintains FY15 View - Analyst Blog", "Luminex Rallies on Positive ARIES Clinical Trial Update - Analyst Blog", "Thermo Fisher Q1 Earnings Top, Revenues Lag Estimates - Analyst Blog", "Cepheid's (CPHD) Xpert HIV-1 Qual Test Gets CE-IVD Mark - Analyst Blog", "Qiagen Grows on Molecular Diagnostics, Americas Disappoint - Analyst Blog", "Cyberonics-Sorin $2.7B Deal Gets US Antitrust Go-Ahead - Analyst Blog", "HeartWare Gets VAD Distribution Approval from Health Canada - Analyst Blog", "Intuitve Surgical's Product Line Strong, Hits 52-Week High - Analyst Blog", "DexCom Hits 52-Week High on Q4 Results, Estimate Revision - Analyst Blog", "Luminex (LMNX) Launches NxTAG RPP for Respiratory Testing - Analyst Blog", "4 Good Investments for Good Friday - Analyst Blog", "Luminex (LMNX) Commences Clinical Trials for ARIES System - Analyst Blog", "Inogen Gains despite Further Delay in Form 10-K Filing - Analyst Blog", "PerkinElmer: 52-Week High on Solid Q4, Positive 2015 View - Analyst Blog", "Fresenius Medical: 52-Week High on Solid Q4, Bright View - Analyst Blog", "The Cooper Companies Seeks License Option from EP Global - Analyst Blog", "Alere (ALR) Touches 52-Week High on Portfolio Expansion - Analyst Blog", "Accuray Expands Internationally, Inks Sales Deal in Canada - Analyst Blog", "ICON Raised to Strong Buy on Stellar Q4, Strategic Acquisition - Analyst Blog", "Air Methods (AIRM) Q4 Earnings Top Estimates, Surge Y/Y - Analyst Blog", "The Cooper Companies Hits 52-Week High on Earnings Beat - Analyst Blog", "Heartware International Posts Q4 Loss; MVAD Holds Promise - Analyst Blog", "The Cooper Companies Tops Q1 Earnings, Lags Revenues - Analyst Blog", "Hologic (HOLX) Continues to Impress: Should You Invest Now? - Analyst Blog", "Accuray CyberKnife M6 with InCise MLC Treats First Patient - Analyst Blog", "NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog", "ICON (ICLR) Posts Stellar Q4 Earnings, Revenues Rise Y/Y - Analyst Blog", "Air Methods (AIRM) Q4 Earnings Top Estimates, Surge Y/Y - Analyst Blog", "The Cooper Companies Hits 52-Week High on Earnings Beat - Analyst Blog", "Omnicare (OCR) Q4 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog", "Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog", "Cyberonics Tops Q3 Earnings, VITARIA System Gets CE Mark - Analyst Blog", "Allscripts (MDRX) Tops Q4 Earnings by a Penny, Revenues Lag - Analyst Blog", "Fresenius Medical Care (FMS) Tops Q4 Earnings, Revenues - Analyst Blog", "DexCom Reports Earnings in Q4, Top Line Surges Y/Y - Analyst Blog", "Healthways Beats Q4 Earnings on Strong Top-Line Growth - Analyst Blog", "Symmetry Surgical Posts Loss in Q4, Revenues Decline Y/Y - Analyst Blog", "Greatbatch Q4 Earnings Top on Solid Margins, Revenues Lag - Analyst Blog", "Adeptus Health Q4 Earnings Miss, Revenues in Line; Up Y/Y - Analyst Blog", "T2 Biosystems (TTOO) Crumbles: Stock Falls by 5.8% - Tale of the Tape", "Teleflex Hits 52-Week High on Strong Q4, Strategic Deals - Analyst Blog", "HeartWare Recalls Old Ventricular Assist System Controllers - Analyst Blog", "Teleflex (TFX) Q4 Earnings, Revenues Top Estimates, Up Y/Y - Analyst Blog", "Exactech (EXAC) Q4 Earnings Top, Revenues Miss Estimates - Analyst Blog", "Merit Medical (MMSI) Q4 Earnings, Sales Top Estimates; Up Y/Y - Analyst Blog", "Greatbatch Q4 Earnings Top on Solid Margins, Revenues Lag - Analyst Blog", "Adeptus Health Q4 Earnings Miss, Revenues in Line; Up Y/Y - Analyst Blog", "T2 Biosystems (TTOO) Crumbles: Stock Falls by 5.8% - Tale of the Tape", "Teleflex Hits 52-Week High on Strong Q4, Strategic Deals - Analyst Blog", "Abiomed Hits 52-Week High on Solid Q3, Impella RP Approval - Analyst Blog", "Cepheid's TB Test Wins FDA Clearance for Expanded Use - Analyst Blog", "Varian Medical's ProBeam Proton Therapy Now in Denmark - Analyst Blog", "Patterson Companies (PDCO) Lags Q3 Earnings, Revenues - Analyst Blog", "Thoratec Beats Q4 Earnings and Revenues, Shares Rise - Analyst Blog", "Luminex (LMNX) Enters Oversold Territory - Tale of the Tape", "Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog", "Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog", "Mettler-Toledo Tops Earnings, Revenues on Margin Strength - Analyst Blog", "Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog", "Edwards Lifesciences Tops Q4 Earnings, Sales; Alters View - Analyst Blog", "Cepheid Strong on Q4, Global Expansion; Currency Woes Stay - Analyst Blog", "Luminex (LMNX): Strong Buy on Solid Q4 & Pipeline Strength - Analyst Blog", "Mid-Morning Market Update: Markets Open Higher; AutoNation Profit Beats Views", "Luminex (LMNX) Q4 Earnings Top, Revenues Meet Estimates - Analyst Blog", "Health Care Sector Update for 02/03/2015: LMNX,ESPR,ONTX", "Tuesday Sector Laggards: Drugs, Biotechnology Stocks", "Why Luminex Corporation Shares Got Slashed", "Luminex Gets Health Canada Approval for Genotyping Assay - Analyst Blog", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Fluidigm (FLDM) Upgraded to Strong Buy on Pipeline Strength - Analyst Blog", "Luminex Grows on Product Launches & Strategic Partnerships - Analyst Blog", "Luminex (LMNX) Upgraded to Strong Buy on Impressive Q3 - Analyst Blog", "Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View", "Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline", "Luminex Tops Q3 Earnings, Revenues in Line; Outlook Weak - Analyst Blog", "Luminex (LMNX) Crumbles: Stock Falls by 7.5% - Tale of the Tape", "Luminex (LMNX) Likely to Miss Earnings Estimates in Q4 - Analyst Blog", "Fluidigm (FLDM) Upgraded to Strong Buy on Pipeline Strength - Analyst Blog", "Luminex Grows on Product Launches & Strategic Partnerships - Analyst Blog", "Luminex (LMNX) Upgraded to Strong Buy on Impressive Q3 - Analyst Blog", "Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View", "Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline", "CVS Forms Pharmacy Care Alliance - Analyst Blog", "Sirona Dental Hits New 52-Week High - Analyst Blog", "Luminex Trends Up, Hits 52-Week High on Strong Q2 Results - Analyst Blog", "Sluggish Chinese Market Continues to Drag Down Mindray Medical - Analyst Blog", "Intuitive Surgical's New da Vinci Robot Gets CE Mark - Analyst Blog", "Hologic's 3D Mammography Improves Breast Cancer Screening - Analyst Blog", "AngioDynamics' Celerity System Wins FDA Nod for PICC - Analyst Blog", "Techne Corporation to Acquire ProteinSimple - Analyst Blog", "Edwards Lifesciences' Aortic Heart Valve Gets FDA Approval - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Bruker's MALDI Biotyper Approved for Biochemical Testing in China - Analyst Blog", "Varian Medical Systems, Prime Healthcare Ink Technology Deal - Analyst Blog", "Masimo Gains on Positive PVI & SpHb Study Data - Analyst Blog", "Surging Earnings Estimates Signal Good News for Luminex (LMNX) - Tale of the Tape", "Sector Update: Healthcare", "Luminex 1Q Earnings Rise 50%, Beat Ests - Analyst Blog", "Mid-Sized Gains for Healthcare Stocks; Luminex Jumps More Than 20% After Dispatching Q1 Analyst Estimates", "Balanced View of Luminex Corporation - Analyst Blog", "DexCom Collaborates with Insulet Corporation - Analyst Blog", "Varian Medical Systems, Prime Healthcare Ink Technology Deal - Analyst Blog", "Masimo Gains on Positive PVI & SpHb Study Data - Analyst Blog", "Surging Earnings Estimates Signal Good News for Luminex (LMNX) - Tale of the Tape", "Sector Update: Healthcare", "Luminex 1Q Earnings Rise 50%, Beat Ests - Analyst Blog", "Mid-Sized Gains for Healthcare Stocks; Luminex Jumps More Than 20% After Dispatching Q1 Analyst Estimates", "Balanced View of Luminex Corporation - Analyst Blog", "Breakthrough for Luminex's xMAP Technology - Analyst Blog", "Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog", "Luminex Remains Neutral - Analyst Blog", "Luminex Corporation (LMNX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Luminex Lags on EPS and Revs, Guides Down - Analyst Blog", "ANGO Launches BioFlo PICC Trial - Analyst Blog", "AngioDynamics Stays Neutral - Analyst Blog", "Commit To Buy Luminex Corp At $15, Earn 10.2% Annualized Using Options", "AngioDynamics Restructures Debt - Analyst Blog", "Luminex Assay Cleared in U.S. and Europe - Analyst Blog", "Arrow Brand Expansion May Boost Teleflex - Analyst Blog", "Bruker Unveils Multimodal Animal Bed - Analyst Blog", "Health Canada Approves ANGO's Celerity System - Analyst Blog", "Bruker to Acquire Prairie Technologies - Analyst Blog", "Abiomed Reiterated at Neutral - Analyst Blog", "Dexcom Retained at Neutral - Analyst Blog", "Masimo Wins New U.S. Client - Analyst Blog", "Cepheid's TB Test OK'd by FDA - Analyst Blog", "Accuray Posts Narrower-than-Expected Loss - Analyst Blog", "Varian Helps Upgrade NHS Hospitals - Analyst Blog", "Abiomed Wins Federal Contract - Analyst Blog", "Cyberonics Tops Earnings Estimates - Analyst Blog", "Hologic Grows Skeletal Health Range - Analyst Blog", "Teleflex Promotes Lung Isolation Product - Analyst Blog", "Insiders Buy Stock at Philip Morris International and Luminex", "Market Wrap for Tuesday, July 30: Technology Sector Rises; Basic Materials Hit Hard", "Good News for Luminex - Analyst Blog", "Luminex Collaborates with NMTC - Analyst Blog", "Luminex and Merck KGaA Extend Ties - Analyst Blog", "In Insider Trading, Tesla Motors Sees a Sale While MoSys CEO Buys Shares", "BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector", "LMNX to Realign Biz, Reduce Headcount - Analyst Blog", "FDA Nod for Luminex Offering - Analyst Blog", "Merck-Luminex' Alzheimer's Collaboration - Analyst Blog", "Luminex Beats EPS, Profits Up - Analyst Blog", "Luminex Wins FDA Clearance - Analyst Blog", "Retaining Luminex at Neutral - Analyst Blog", "Luminex Beats on Assay Boost - Analyst Blog", "Luminex Wins Technology Award - Analyst Blog"], "Elapsed Time": ["JUN 15, 2020", "MAY 24, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 15, 2020", "MAY 8, 2020", "MAY 8, 2020", "MAY 4, 2020", "JUN 15, 2020", "JAN 16, 2020", "DEC 17, 2019", "NOV 12, 2019", "NOV 11, 2019", "NOV 4, 2019", "SEP 23, 2019", "MAR 2, 2020", "FEB 10, 2020", "JAN 16, 2020", "DEC 17, 2019", "NOV 12, 2019", "NOV 11, 2019", "FEB 15, 2019", "FEB 6, 2019", "JUL 31, 2019", "APR 22, 2019", "MAR 26, 2019", "MAR 19, 2019", "MAR 6, 2019", "FEB 21, 2019", "FEB 15, 2019", "FEB 6, 2019", "JUL 31, 2019", "APR 22, 2019", "MAR 26, 2019", "MAR 19, 2019", "MAR 6, 2019", "FEB 21, 2019", "FEB 15, 2019", "FEB 6, 2019", "JUL 31, 2019", "APR 22, 2019", "MAR 26, 2019", "MAR 19, 2019", "MAR 6, 2019", "FEB 21, 2019", "FEB 15, 2019", "JAN 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 9, 2019", "JAN 7, 2019", "JAN 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 9, 2019", "JAN 7, 2019", "JAN 4, 2019", "FEB 4, 2019", "DEC 18, 2018", "DEC 18, 2018", "DEC 5, 2018", "NOV 7, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 5, 2018", "JAN 3, 2019", "DEC 18, 2018", "DEC 18, 2018", "DEC 5, 2018", "NOV 7, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 5, 2018", "JAN 3, 2019", "DEC 18, 2018", "DEC 18, 2018", "DEC 5, 2018", "NOV 7, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 5, 2018", "JAN 3, 2019", "OCT 25, 2018", "OCT 25, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 11, 2018", "OCT 29, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 11, 2018", "OCT 29, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 23, 2018", "SEP 19, 2018", "SEP 5, 2018", "AUG 16, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 7, 2018", "AUG 3, 2018", "JUL 18, 2018", "SEP 19, 2018", "MAY 9, 2018", "MAR 26, 2018", "MAR 21, 2018", "MAR 14, 2018", "MAR 6, 2018", "FEB 21, 2018", "FEB 13, 2018", "JUN 20, 2018", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 18, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 19, 2017", "DEC 18, 2017", "DEC 20, 2017", "DEC 1, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 14, 2017", "DEC 11, 2017", "NOV 27, 2017", "NOV 24, 2017", "NOV 28, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 29, 2017", "NOV 28, 2017", "NOV 30, 2017", "NOV 23, 2017", "NOV 21, 2017", "NOV 21, 2017", "NOV 21, 2017", "NOV 16, 2017", "NOV 16, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 9, 2017", "NOV 9, 2017", "NOV 8, 2017", "NOV 8, 2017", "NOV 9, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 6, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 3, 2017", "NOV 7, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "OCT 25, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 16, 2017", "OCT 13, 2017", "OCT 13, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 9, 2017", "OCT 4, 2017", "SEP 27, 2017", "SEP 20, 2017", "SEP 20, 2017", "SEP 19, 2017", "SEP 14, 2017", "OCT 3, 2017", "AUG 25, 2017", "AUG 8, 2017", "JUN 29, 2017", "JUN 29, 2017", "JUN 28, 2017", "JUN 28, 2017", "SEP 7, 2017", "AUG 30, 2017", "AUG 25, 2017", "AUG 8, 2017", "JUN 29, 2017", "JUN 29, 2017", "JUN 28, 2017", "JUN 28, 2017", "SEP 7, 2017", "JUN 28, 2017", "JUN 27, 2017", "JUN 27, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 23, 2017", "JUN 28, 2017", "JUN 22, 2017", "JUN 22, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 23, 2017", "JUN 19, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 15, 2017", "JUN 14, 2017", "JUN 13, 2017", "JUN 19, 2017", "JUN 5, 2017", "JUN 5, 2017", "JUN 5, 2017", "JUN 2, 2017", "JUN 2, 2017", "JUN 2, 2017", "JUN 2, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 5, 2017", "JUN 5, 2017", "JUN 1, 2017", "JUN 1, 2017", "MAY 31, 2017", "MAY 31, 2017", "JUN 2, 2017", "MAY 31, 2017", "MAY 31, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 30, 2017", "MAY 31, 2017", "MAY 30, 2017", "MAY 29, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 30, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 23, 2017", "MAY 22, 2017", "MAY 24, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 22, 2017", "MAY 24, 2017", "MAY 22, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 18, 2017", "MAY 18, 2017", "MAY 22, 2017", "MAY 18, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 16, 2017", "MAY 16, 2017", "MAY 18, 2017", "MAY 15, 2017", "MAY 15, 2017", "MAY 11, 2017", "MAY 2, 2017", "MAY 2, 2017", "APR 4, 2017", "MAR 21, 2017", "MAY 16, 2017", "FEB 7, 2017", "FEB 3, 2017", "FEB 3, 2017", "JAN 11, 2017", "JAN 5, 2017", "DEC 6, 2016", "NOV 18, 2016", "MAR 9, 2017", "OCT 28, 2016", "OCT 27, 2016", "OCT 26, 2016", "AUG 30, 2016", "AUG 15, 2016", "AUG 3, 2016", "JUL 7, 2016", "NOV 3, 2016", "JUN 27, 2016", "JUN 2, 2016", "JUN 2, 2016", "MAY 23, 2016", "MAY 23, 2016", "MAY 23, 2016", "MAY 23, 2016", "JUL 4, 2016", "JUN 27, 2016", "JUN 2, 2016", "JUN 2, 2016", "MAY 23, 2016", "MAY 23, 2016", "MAY 23, 2016", "MAY 23, 2016", "JUL 4, 2016", "MAY 16, 2016", "MAY 16, 2016", "MAY 16, 2016", "MAR 23, 2016", "MAR 22, 2016", "MAR 18, 2016", "MAR 17, 2016", "MAY 5, 2016", "MAR 16, 2016", "MAR 15, 2016", "MAR 15, 2016", "MAR 15, 2016", "MAR 14, 2016", "MAR 14, 2016", "MAR 11, 2016", "MAR 16, 2016", "MAR 16, 2016", "MAR 15, 2016", "MAR 15, 2016", "MAR 15, 2016", "MAR 14, 2016", "MAR 14, 2016", "MAR 8, 2016", "MAR 11, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 3, 2016", "MAR 3, 2016", "MAR 2, 2016", "MAR 7, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 26, 2016", "FEB 25, 2016", "FEB 25, 2016", "FEB 24, 2016", "MAR 1, 2016", "FEB 23, 2016", "FEB 23, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 19, 2016", "FEB 18, 2016", "FEB 17, 2016", "FEB 24, 2016", "FEB 17, 2016", "FEB 17, 2016", "FEB 16, 2016", "FEB 15, 2016", "FEB 12, 2016", "FEB 12, 2016", "FEB 12, 2016", "FEB 17, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 11, 2016", "FEB 3, 2016", "FEB 2, 2016", "FEB 2, 2016", "DEC 21, 2015", "DEC 7, 2015", "JUN 18, 2015", "NOV 5, 2015", "NOV 3, 2015", "OCT 29, 2015", "OCT 22, 2015", "OCT 8, 2015", "AUG 4, 2015", "APR 20, 2015", "APR 20, 2015", "JUN 14, 2015", "JUN 9, 2015", "JUN 1, 2015", "MAY 5, 2015", "APR 29, 2015", "APR 22, 2015", "APR 20, 2015", "APR 20, 2015", "APR 15, 2015", "APR 15, 2015", "APR 14, 2015", "APR 10, 2015", "APR 7, 2015", "APR 2, 2015", "MAR 31, 2015", "APR 16, 2015", "MAR 19, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 11, 2015", "MAR 11, 2015", "MAR 3, 2015", "MAR 9, 2015", "MAR 6, 2015", "MAR 6, 2015", "MAR 6, 2015", "MAR 5, 2015", "MAR 4, 2015", "MAR 3, 2015", "MAR 3, 2015", "MAR 9, 2015", "MAR 2, 2015", "MAR 2, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 26, 2015", "FEB 26, 2015", "FEB 26, 2015", "MAR 2, 2015", "FEB 25, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 23, 2015", "FEB 19, 2015", "FEB 25, 2015", "FEB 25, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 17, 2015", "FEB 16, 2015", "FEB 13, 2015", "FEB 19, 2015", "FEB 11, 2015", "FEB 10, 2015", "FEB 9, 2015", "FEB 9, 2015", "FEB 6, 2015", "FEB 5, 2015", "FEB 4, 2015", "FEB 12, 2015", "FEB 4, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 2, 2015", "FEB 4, 2015", "DEC 29, 2014", "DEC 1, 2014", "OCT 29, 2014", "OCT 28, 2014", "OCT 28, 2014", "OCT 28, 2014", "OCT 16, 2014", "JAN 30, 2015", "DEC 29, 2014", "DEC 1, 2014", "OCT 29, 2014", "OCT 28, 2014", "OCT 28, 2014", "JUN 30, 2014", "JUN 27, 2014", "OCT 9, 2014", "JUN 27, 2014", "JUN 26, 2014", "JUN 25, 2014", "JUN 19, 2014", "JUN 18, 2014", "JUN 17, 2014", "JUN 16, 2014", "JUN 27, 2014", "JUN 16, 2014", "JUN 10, 2014", "MAY 14, 2014", "APR 29, 2014", "APR 29, 2014", "APR 29, 2014", "APR 14, 2014", "JUN 16, 2014", "JUN 16, 2014", "JUN 10, 2014", "MAY 14, 2014", "APR 29, 2014", "APR 29, 2014", "APR 29, 2014", "APR 14, 2014", "MAR 19, 2014", "FEB 5, 2014", "DEC 2, 2013", "NOV 29, 2013", "NOV 5, 2013", "OCT 7, 2013", "OCT 3, 2013", "APR 11, 2014", "SEP 26, 2013", "SEP 24, 2013", "SEP 23, 2013", "SEP 20, 2013", "SEP 19, 2013", "SEP 18, 2013", "SEP 12, 2013", "SEP 30, 2013", "SEP 10, 2013", "AUG 29, 2013", "AUG 28, 2013", "AUG 28, 2013", "AUG 27, 2013", "AUG 23, 2013", "AUG 15, 2013", "SEP 10, 2013", "AUG 7, 2013", "JUL 30, 2013", "JUL 23, 2013", "JUN 14, 2013", "MAY 31, 2013", "MAY 21, 2013", "MAY 14, 2013", "MAY 1, 2013", "APR 19, 2013", "MAR 19, 2013", "FEB 5, 2013", "JAN 16, 2013", "FEB 10, 2012", "FEB 7, 2012", "SEP 7, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/ex-dividend-reminder%3A-wingstop-aarons-and-luminex-2020-06-15", "https://www.nasdaq.com/articles/wall-st-week-ahead-investors-look-beyond-drug-makers-as-hunt-for-covid-19-treatment-1", "https://www.nasdaq.com/articles/wall-st-week-ahead-investors-look-beyond-drug-makers-as-hunt-for-covid-19-treatment-0", "https://www.nasdaq.com/articles/wall-st-week-ahead-investors-look-beyond-drug-makers-as-hunt-for-covid-19-treatment-heats", "https://www.nasdaq.com/articles/interesting-lmnx-put-and-call-options-for-january-2021-2020-05-15", "https://www.nasdaq.com/articles/why-luminex-shares-are-tumbling-13.5-today-2020-05-08", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-banks-boeing-uber-disney-2020-05-08", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q1-2020-earnings-call-transcript-2020-05-05", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-wingstop-aarons-and-luminex-2020-06-15", "https://www.nasdaq.com/articles/strategy-to-yieldboost-lmnx-from-1.5-to-15-using-options-2020-01-16", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-for-december-18-2019-2019-12-17", "https://www.nasdaq.com/articles/3-cheap-dividend-stocks-trading-near-their-52-week-lows-2019-11-12", "https://www.nasdaq.com/articles/monday-11-11-insider-buying-report%3A-lila-lmnx-2019-11-11", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q3-2019-earnings-call-transcript-2019-11-05", "https://www.nasdaq.com/articles/cash-dividend-on-the-way-from-luminex-lmnx-2019-09-23", "https://www.nasdaq.com/articles/insiders-were-right%3A-lmnx-makes-new-52-week-high-2020-03-02", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q4-2019-earnings-call-transcript-2020-02-11", "https://www.nasdaq.com/articles/strategy-to-yieldboost-lmnx-from-1.5-to-15-using-options-2020-01-16", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-for-december-18-2019-2019-12-17", "https://www.nasdaq.com/articles/3-cheap-dividend-stocks-trading-near-their-52-week-lows-2019-11-12", "https://www.nasdaq.com/articles/monday-11-11-insider-buying-report%3A-lila-lmnx-2019-11-11", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-lng-lmnx-ibm-2019-02-15", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-2019-guidance-lacks-luster-2019-02-06", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q2-2019-earnings-call-transcript-2019-08-01", "https://www.nasdaq.com/articles/notable-monday-option-activity-lmnx-dpz-mmm-2019-04-22", "https://www.nasdaq.com/articles/commit-purchase-luminex-corp-2250-earn-169-annualized-using-options-2019-03-26", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-march-20-2019-2019-03-19", "https://www.nasdaq.com/articles/luminex-lmnx-down-2.7-since-last-earnings-report%3A-can-it-rebound-2019-03-06", "https://www.nasdaq.com/articles/luminex-hurt-by-segmental-sluggishness-stiff-competition-2019-02-21", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-lng-lmnx-ibm-2019-02-15", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-2019-guidance-lacks-luster-2019-02-06", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q2-2019-earnings-call-transcript-2019-08-01", "https://www.nasdaq.com/articles/notable-monday-option-activity-lmnx-dpz-mmm-2019-04-22", "https://www.nasdaq.com/articles/commit-purchase-luminex-corp-2250-earn-169-annualized-using-options-2019-03-26", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-march-20-2019-2019-03-19", "https://www.nasdaq.com/articles/luminex-lmnx-down-2.7-since-last-earnings-report%3A-can-it-rebound-2019-03-06", "https://www.nasdaq.com/articles/luminex-hurt-by-segmental-sluggishness-stiff-competition-2019-02-21", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-lng-lmnx-ibm-2019-02-15", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-2019-guidance-lacks-luster-2019-02-06", "https://www.nasdaq.com/articles/luminex-corp-de-lmnx-q2-2019-earnings-call-transcript-2019-08-01", "https://www.nasdaq.com/articles/notable-monday-option-activity-lmnx-dpz-mmm-2019-04-22", "https://www.nasdaq.com/articles/commit-purchase-luminex-corp-2250-earn-169-annualized-using-options-2019-03-26", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-march-20-2019-2019-03-19", "https://www.nasdaq.com/articles/luminex-lmnx-down-2.7-since-last-earnings-report%3A-can-it-rebound-2019-03-06", "https://www.nasdaq.com/articles/luminex-hurt-by-segmental-sluggishness-stiff-competition-2019-02-21", "https://www.nasdaq.com/articles/heres-why-investors-should-hold-luminex-lmnx-stock-now-2019-01-07", "https://www.nasdaq.com/articles/lmnx-or-pacb%3A-which-is-a-better-medtech-investment-pick-2019-01-04", "https://www.nasdaq.com/articles/luminex-corp-lmnx-q4-2018-earnings-conference-call-transcript-2019-02-04", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-estimates-2019-02-04", "https://www.nasdaq.com/articles/earnings-reaction-history-luminex-corporation-500-follow-through-indicator-86-sensitive", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-lmnx-2019-01-29", "https://www.nasdaq.com/articles/earnings-preview%3A-luminex-lmnx-q4-earnings-expected-to-decline-2019-01-28", "https://www.nasdaq.com/articles/luminexs-lmnx-preliminary-q4-results-cheer-investors-2019-01-09", "https://www.nasdaq.com/articles/heres-why-investors-should-hold-luminex-lmnx-stock-now-2019-01-07", "https://www.nasdaq.com/articles/lmnx-or-pacb%3A-which-is-a-better-medtech-investment-pick-2019-01-04", "https://www.nasdaq.com/articles/luminex-corp-lmnx-q4-2018-earnings-conference-call-transcript-2019-02-04", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-estimates-2019-02-04", "https://www.nasdaq.com/articles/earnings-reaction-history-luminex-corporation-500-follow-through-indicator-86-sensitive", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-lmnx-2019-01-29", "https://www.nasdaq.com/articles/earnings-preview%3A-luminex-lmnx-q4-earnings-expected-to-decline-2019-01-28", "https://www.nasdaq.com/articles/luminexs-lmnx-preliminary-q4-results-cheer-investors-2019-01-09", "https://www.nasdaq.com/articles/heres-why-investors-should-hold-luminex-lmnx-stock-now-2019-01-07", "https://www.nasdaq.com/articles/lmnx-or-pacb%3A-which-is-a-better-medtech-investment-pick-2019-01-04", "https://www.nasdaq.com/articles/luminex-corp-lmnx-q4-2018-earnings-conference-call-transcript-2019-02-04", "https://www.nasdaq.com/articles/ex-dividend-reminder-luminex-qts-realty-trust-and-chubb-2018-12-18", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-december-19-2018-2018-12-18", "https://www.nasdaq.com/articles/why-is-luminex-lmnx-up-12.4-since-last-earnings-report-2018-12-05", "https://www.nasdaq.com/articles/luminexs-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-07", "https://www.nasdaq.com/articles/luminex-breaks-below-200-day-moving-average-notable-lmnx-2018-11-06", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-q3-earnings-conference-call-transcript-2018-11-05", "https://www.nasdaq.com/articles/luminex-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-05", "https://www.nasdaq.com/articles/luminex-buys-milliporesigmas-flow-cytometry-unit-for-%2475m-2019-01-03", "https://www.nasdaq.com/articles/ex-dividend-reminder-luminex-qts-realty-trust-and-chubb-2018-12-18", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-december-19-2018-2018-12-18", "https://www.nasdaq.com/articles/why-is-luminex-lmnx-up-12.4-since-last-earnings-report-2018-12-05", "https://www.nasdaq.com/articles/luminexs-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-07", "https://www.nasdaq.com/articles/luminex-breaks-below-200-day-moving-average-notable-lmnx-2018-11-06", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-q3-earnings-conference-call-transcript-2018-11-05", "https://www.nasdaq.com/articles/luminex-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-05", "https://www.nasdaq.com/articles/luminex-buys-milliporesigmas-flow-cytometry-unit-for-%2475m-2019-01-03", "https://www.nasdaq.com/articles/ex-dividend-reminder-luminex-qts-realty-trust-and-chubb-2018-12-18", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-december-19-2018-2018-12-18", "https://www.nasdaq.com/articles/why-is-luminex-lmnx-up-12.4-since-last-earnings-report-2018-12-05", "https://www.nasdaq.com/articles/luminexs-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-07", "https://www.nasdaq.com/articles/luminex-breaks-below-200-day-moving-average-notable-lmnx-2018-11-06", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-q3-earnings-conference-call-transcript-2018-11-05", "https://www.nasdaq.com/articles/luminex-lmnx-q3-earnings-and-revenues-miss-estimates-2018-11-05", "https://www.nasdaq.com/articles/luminex-buys-milliporesigmas-flow-cytometry-unit-for-%2475m-2019-01-03", "https://www.nasdaq.com/articles/will-advance-medical-buyout-aid-teladoc-tdoc-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/can-cag-growth-steadily-drive-idexx-idxx-in-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/will-robust-icl-sales-aid-staar-surgical-staa-q3-earnings-2018-10-24", "https://www.nasdaq.com/articles/will-amedisys-amed-q3-earnings-reflect-overall-gain-2018-10-24", "https://www.nasdaq.com/articles/whats-in-store-for-medpace-holdings-medp-in-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/will-global-industrial-unit-boost-ecolabs-ecl-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/molecular-diagnostic-market-gains-momentum-3-stocks-focus-2018-10-11", "https://www.nasdaq.com/articles/luminex-lmnx-q3-earnings-preview%3A-what-to-expect-2018-10-29", "https://www.nasdaq.com/articles/will-advance-medical-buyout-aid-teladoc-tdoc-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/can-cag-growth-steadily-drive-idexx-idxx-in-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/will-robust-icl-sales-aid-staar-surgical-staa-q3-earnings-2018-10-24", "https://www.nasdaq.com/articles/will-amedisys-amed-q3-earnings-reflect-overall-gain-2018-10-24", "https://www.nasdaq.com/articles/whats-in-store-for-medpace-holdings-medp-in-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/will-global-industrial-unit-boost-ecolabs-ecl-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/molecular-diagnostic-market-gains-momentum-3-stocks-focus-2018-10-11", "https://www.nasdaq.com/articles/luminex-lmnx-q3-earnings-preview%3A-what-to-expect-2018-10-29", "https://www.nasdaq.com/articles/will-advance-medical-buyout-aid-teladoc-tdoc-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/can-cag-growth-steadily-drive-idexx-idxx-in-q3-earnings-2018-10-25", "https://www.nasdaq.com/articles/will-robust-icl-sales-aid-staar-surgical-staa-q3-earnings-2018-10-24", "https://www.nasdaq.com/articles/will-amedisys-amed-q3-earnings-reflect-overall-gain-2018-10-24", "https://www.nasdaq.com/articles/whats-in-store-for-medpace-holdings-medp-in-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/will-global-industrial-unit-boost-ecolabs-ecl-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-september-20-2018-2018-09-19", "https://www.nasdaq.com/articles/why-is-luminex-lmnx-up-15-since-last-earnings-report-2018-09-05", "https://www.nasdaq.com/articles/itgr-or-lmnx%3A-which-is-the-better-value-stock-right-now-2018-08-16", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-882018-2018-08-08", "https://www.nasdaq.com/articles/luminex-lmnx-misses-on-earnings-in-q2-margins-contract-2018-08-07", "https://www.nasdaq.com/articles/mid-afternoon-market-update-commercial-vehicle-group-rises-earnings-beat-luminex-shares", "https://www.nasdaq.com/articles/medical-product-stock-earnings-on-aug-6%3A-cah-hsic-more-2018-08-03", "https://www.nasdaq.com/articles/luminex-lmnx-looks-good%3A-stock-adds-5.7-in-session-2018-07-18", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-september-20-2018-2018-09-19", "https://www.nasdaq.com/articles/luminex-lmnx-beats-q1-estimates-on-aries-platform-strength-2018-05-09", "https://www.nasdaq.com/articles/luminex-lmnx-product-portfolio-solid-competition-rife-2018-03-26", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-march-22-2018-2018-03-21", "https://www.nasdaq.com/articles/why-is-luminex-lmnx-up-11.2-since-its-last-earnings-report-2018-03-14", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-362018-2018-03-06", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-solid-product-line-competition-rife-2018-02-21", "https://www.nasdaq.com/articles/luminex-lmnx-beats-on-q4-earnings-revenues-issues-view-2018-02-13", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-june-21-2018-2018-06-20", "https://www.nasdaq.com/articles/dexcom-dxcm-banks-on-collaborations-competition-rife-2017-12-20", "https://www.nasdaq.com/articles/nuvasive-nuva-global-prospects-solid-pricing-woes-remain-2017-12-20", "https://www.nasdaq.com/articles/innovation-partnership-aid-genomic-health-cost-woe-remains-2017-12-20", "https://www.nasdaq.com/articles/transenterix-gbil-ink-deal-to-commercialize-surgibot-system-2017-12-19", "https://www.nasdaq.com/articles/amedisys-amed-banks-on-personal-care-amid-margin-woes-2017-12-19", "https://www.nasdaq.com/articles/ecolab-cargill-and-techstars-launch-accelerator-program-2017-12-19", "https://www.nasdaq.com/articles/express-scripts-buys-evicore-for-%243.6b-forays-into-mbm-2017-12-18", "https://www.nasdaq.com/articles/perkinelmer-pki-closes-euroimmun-acquisition-for-%241.3b-2017-12-20", "https://www.nasdaq.com/articles/dexcom-dxcm-banks-on-collaborations-competition-rife-2017-12-20", "https://www.nasdaq.com/articles/nuvasive-nuva-global-prospects-solid-pricing-woes-remain-2017-12-20", "https://www.nasdaq.com/articles/innovation-partnership-aid-genomic-health-cost-woe-remains-2017-12-20", "https://www.nasdaq.com/articles/transenterix-gbil-ink-deal-to-commercialize-surgibot-system-2017-12-19", "https://www.nasdaq.com/articles/amedisys-amed-banks-on-personal-care-amid-margin-woes-2017-12-19", "https://www.nasdaq.com/articles/ecolab-cargill-and-techstars-launch-accelerator-program-2017-12-19", "https://www.nasdaq.com/articles/express-scripts-buys-evicore-for-%243.6b-forays-into-mbm-2017-12-18", "https://www.nasdaq.com/articles/perkinelmer-pki-closes-euroimmun-acquisition-for-%241.3b-2017-12-20", "https://www.nasdaq.com/articles/myriad-genetics-presents-favorable-embraca-trial-results-2017-12-18", "https://www.nasdaq.com/articles/wright-medical-wmgi-acquires-imascap-sas-for-%2488.8-million-2017-12-15", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-illumina-ilmn-stock-now-2017-12-15", "https://www.nasdaq.com/articles/myriad-genetics-rides-on-solid-molecular-diagnostics-suite-2017-12-14", "https://www.nasdaq.com/articles/cooper-companies-coo-tops-q4-earnings-revenue-estimates-2017-12-11", "https://www.nasdaq.com/articles/hologics-fda-nod-for-quantra-software-boosts-breast-health-2017-11-27", "https://www.nasdaq.com/articles/heres-why-you-should-add-amedisys-amed-to-your-portfolio-2017-11-24", "https://www.nasdaq.com/articles/edwards-lifesciences-pipeline-strong-amid-rising-expenses-2017-11-28", "https://www.nasdaq.com/articles/varians-partners-penn-medicine-proton-therapy-in-focus-2017-11-30", "https://www.nasdaq.com/articles/flexions-flxn-zilretta-therapy-to-fast-capture-oa-market-2017-11-30", "https://www.nasdaq.com/articles/genomic-health-cleveland-diagnostics-deal-to-boost-test-suite-2017-11-29", "https://www.nasdaq.com/articles/gnc-holdings-grapples-with-margin-weakness-stiff-competition-2017-11-29", "https://www.nasdaq.com/articles/stryker-gains-ground-on-mako-robotic-unit-amid-forex-woes-2017-11-29", "https://www.nasdaq.com/articles/labcorps-covance-business-bounces-back-on-chiltern-buyout-2017-11-29", "https://www.nasdaq.com/articles/align-technology-algn-grows-on-invisalign-system-strength-2017-11-28", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-baxter-bax-stock-right-now-2017-11-30", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-align-technology-algn-now-2017-11-23", "https://www.nasdaq.com/articles/medtronic-mdt-beats-on-q2-earnings-reiterates-fy18-view-2017-11-21", "https://www.nasdaq.com/articles/patterson-companies-pdco-misses-on-q2-earnings-cuts-view-2017-11-21", "https://www.nasdaq.com/articles/five-scorching-hot-strong-buy-stocks-2017-11-21", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-11-16", "https://www.nasdaq.com/articles/heres-why-investors-should-buy-myriad-genetics-right-now-2017-11-16", "https://www.nasdaq.com/articles/myriad-genetics-latest-alliance-to-boost-genesight-reach-2017-11-15", "https://www.nasdaq.com/articles/davita-issues-downbeat-17-view-hurricanes-affect-q3-results-2017-11-15", "https://www.nasdaq.com/articles/heres-why-investors-should-buy-luminex-lmnx-right-now-2017-11-15", "https://www.nasdaq.com/articles/quest-diagnostics-clinical-genomics-ally-oncology-strong-2017-11-14", "https://www.nasdaq.com/articles/weight-watchers-wtw-to-issue-%24500m-senior-notes-due-2025-2017-11-14", "https://www.nasdaq.com/articles/surmodics-srdx-posts-earnings-in-q4-revenues-top-estimates-2017-11-09", "https://www.nasdaq.com/articles/dull-mfa-mineral-nutrition-sales-hurt-phirbo-rivalry-rife-2017-11-09", "https://www.nasdaq.com/articles/haemonetics-hae-q2-earnings-beat-estimates-eps-view-up-2017-11-08", "https://www.nasdaq.com/articles/vwr-q3-earnings-top-sell-off-to-avantor-approaching-closure-2017-11-08", "https://www.nasdaq.com/articles/hill-rom-hrc-banks-on-product-launches-competition-rife-2017-11-09", "https://www.nasdaq.com/articles/hill-rom-hrc-q4-earnings-and-revenues-top-margins-up-2017-11-06", "https://www.nasdaq.com/articles/cvs-health-cvs-beats-q3-earnings-estimates-updates-view-2017-11-06", "https://www.nasdaq.com/articles/henry-schein-hsic-misses-q3-earnings-margins-decline-2017-11-06", "https://www.nasdaq.com/articles/conmed-cnmd-q3-earnings-and-revenues-beat-margin-down-2017-11-06", "https://www.nasdaq.com/articles/bioscrip-bios-q3-loss-wider-than-expected-revenues-miss-2017-11-03", "https://www.nasdaq.com/articles/bruker-brkr-q3-earnings-revenues-beat-estimates-view-up-2017-11-03", "https://www.nasdaq.com/articles/allscripts-mdrx-q3-earnings-meet-revenues-beat-estimates-2017-11-03", "https://www.nasdaq.com/articles/mckesson-mck-to-acquire-rxcrossroads-for-%24735-million-2017-11-07", "https://www.nasdaq.com/articles/dentsply-xray-earnings-and-revenues-beat-estimates-in-q3-2017-11-03", "https://www.nasdaq.com/articles/align-technology-algn-gains-on-invisalign-competition-rife-2017-11-02", "https://www.nasdaq.com/articles/masimo-masi-beats-on-q3-earnings-and-revenues-raises-view-2017-11-01", "https://www.nasdaq.com/articles/abiomed-abmd-looks-good%3A-stock-adds-7.5-in-session-2017-11-01", "https://www.nasdaq.com/articles/luminex-lmnx-tops-q3-earnings-meets-revenue-estimates-2017-10-31", "https://www.nasdaq.com/articles/express-scripts-esrx-q3-earnings-in-line-fy17-view-up-2017-10-25", "https://www.nasdaq.com/articles/davita-banks-on-acquisitions-escalating-expenses-a-concern-2017-10-09", "https://www.nasdaq.com/articles/athenahealth-athn-beats-earnings-misses-revenues-in-q3-2017-10-20", "https://www.nasdaq.com/articles/heres-why-investors-should-sell-patterson-companies-now-2017-10-16", "https://www.nasdaq.com/articles/heres-why-investors-should-sell-ecolab-ecl-right-away-2017-10-13", "https://www.nasdaq.com/articles/opko-health-opk-signs-new-agreement-with-japan-tobacco-2017-10-13", "https://www.nasdaq.com/articles/perkinelmer-hits-a-52-week-high%3A-whats-driving-the-stock-2017-10-06", "https://www.nasdaq.com/articles/masimo-masi-launches-trace-data-and-reporting-tool-in-us-2017-10-06", "https://www.nasdaq.com/articles/genomic-healths-cost-pressure-mounts-cancer-tests-strong-2017-10-05", "https://www.nasdaq.com/articles/integra-rides-high-on-product-launches-competition-rife-2017-10-05", "https://www.nasdaq.com/articles/teleflex-tfx-hits-a-52-week-high-on-neotract-acquisition-2017-10-09", "https://www.nasdaq.com/articles/hill-rom-hrc-rides-on-product-launches-competition-rife-2017-10-04", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-09-27", "https://www.nasdaq.com/articles/alcoa-cheesecake-factory-luminex-ligand-pharmaceuticals-and-centene-highlighted-as-zacks", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-september-21-2017-2017-09-20", "https://www.nasdaq.com/articles/3-healthcare-stocks-buy-renewed-obamacare-repeal-talks-2017-09-19", "https://www.nasdaq.com/articles/heres-why-investors-should-buy-luminex-lmnx-right-now-2017-09-14", "https://www.nasdaq.com/articles/quest-diagnostics-buys-2-outreach-labs-widens-customer-base-2017-10-03", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-08-25", "https://www.nasdaq.com/articles/luminex-lmnx-beats-earnings-revenue-estimates-in-q2-2017-08-08", "https://www.nasdaq.com/articles/dentsply-sirona-renews-canadian-distribution-agreement-2017-06-29", "https://www.nasdaq.com/articles/luminex-gets-ce-mark-for-aries-norovirus-assay-shares-rally-2017-06-29", "https://www.nasdaq.com/articles/cryolife-hits-a-52-week-high%3A-whats-driving-the-stock-2017-06-28", "https://www.nasdaq.com/articles/express-scripts-gains-from-increased-generic-utilization-2017-06-28", "https://www.nasdaq.com/articles/luminex-lmnx-down-2.5-since-earnings-report%3A-can-it-rebound-2017-09-07", "https://www.nasdaq.com/articles/luminex-partners-sutter-health-to-boost-molecular-testing-2017-08-30", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-08-25", "https://www.nasdaq.com/articles/luminex-lmnx-beats-earnings-revenue-estimates-in-q2-2017-08-08", "https://www.nasdaq.com/articles/dentsply-sirona-renews-canadian-distribution-agreement-2017-06-29", "https://www.nasdaq.com/articles/luminex-gets-ce-mark-for-aries-norovirus-assay-shares-rally-2017-06-29", "https://www.nasdaq.com/articles/cryolife-hits-a-52-week-high%3A-whats-driving-the-stock-2017-06-28", "https://www.nasdaq.com/articles/express-scripts-gains-from-increased-generic-utilization-2017-06-28", "https://www.nasdaq.com/articles/luminex-lmnx-down-2.5-since-earnings-report%3A-can-it-rebound-2017-09-07", "https://www.nasdaq.com/articles/what-drove-becton-dickinson-bdx-to-a-new-52-week-high-2017-06-28", "https://www.nasdaq.com/articles/quintiles-q-oce-software-to-simplify-commercial-functions-2017-06-27", "https://www.nasdaq.com/articles/medidata-mdso-inventiv-enter-into-multi-year-partnership-2017-06-27", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-rci-hospitality-holdings-hr-block-sturm-ruger-company", "https://www.nasdaq.com/articles/conformis-cfms-gets-fda-approval-for-itotal-hip-system-2017-06-26", "https://www.nasdaq.com/articles/merit-medical-embosphere-gets-fda-de-novo-classification-2017-06-26", "https://www.nasdaq.com/articles/want-to-combat-market-volatility-buy-5-low-beta-stocks-2017-06-23", "https://www.nasdaq.com/articles/varian-rides-on-oncology-and-proton-therapy-businesses-2017-06-28", "https://www.nasdaq.com/articles/pra-health-hits-a-52-week-high-on-strategic-acquisitions-2017-06-22", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-portfolio-strength-view-impressive-2017-06-22", "https://www.nasdaq.com/articles/medidata-solutions-mdso-set-to-join-the-sp-400-index-2017-06-21", "https://www.nasdaq.com/articles/luminex-lmnx-scores-a-strong-buy-right-now%3A-heres-how-2017-06-20", "https://www.nasdaq.com/articles/pra-health-prah-shares-rally-on-partnership-with-jumo-2017-06-20", "https://www.nasdaq.com/articles/neogen-offers-neoseek-genomic-services-to-ensure-food-safety-2017-06-20", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-june-21-2017-2017-06-20", "https://www.nasdaq.com/articles/evolent-health-evh-prices-4.5m-follow-on-share-offering-2017-06-23", "https://www.nasdaq.com/articles/dentsply-xray-renews-partnership-with-pacific-dental-2017-06-19", "https://www.nasdaq.com/articles/pacific-biosciences-pacb-prices-offering-of-common-stock-2017-06-16", "https://www.nasdaq.com/articles/varian-showcases-halcyon-system-at-degro-meet-stock-up-2017-06-16", "https://www.nasdaq.com/articles/transenterix-sells-surgery-system-to-japanese-university-2017-06-16", "https://www.nasdaq.com/articles/baxter-dorizoe-ink-deal-to-expand-generic-injectables-line-2017-06-15", "https://www.nasdaq.com/articles/conmed-cnmd-hits-a-52-week-high%3A-whats-driving-the-stock-2017-06-14", "https://www.nasdaq.com/articles/luminexs-lmnx-verigene-panels-receive-approval-in-japan-2017-06-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-luminex-zimmer-biomet-holdings-and-pembina-pipeline-2017-06-19", "https://www.nasdaq.com/articles/align-sets-up-manufacturing-center-in-china-grows-in-apac-2017-06-05", "https://www.nasdaq.com/articles/inogen-secures-new-direct-to-consumer-business-facility-2017-06-05", "https://www.nasdaq.com/articles/rti-surgical-now-part-of-us-based-manufacturing-initiative-2017-06-05", "https://www.nasdaq.com/articles/mead-johnsons-shareholders-approve-reckitt-benckiser-deal-2017-06-02", "https://www.nasdaq.com/articles/hill-rom-holdings-hits-52-week-high-on-solid-product-line-2017-06-02", "https://www.nasdaq.com/articles/the-cooper-companies-coo-beats-earnings-estimates-in-q2-2017-06-02", "https://www.nasdaq.com/articles/edwards-lifesciences-tavr-international-prospects-solid-2017-06-02", "https://www.nasdaq.com/articles/cerner-cern-to-develop-electronic-health-records-system-2017-06-06", "https://www.nasdaq.com/articles/align-sets-up-manufacturing-center-in-china-grows-in-apac-2017-06-05", "https://www.nasdaq.com/articles/inogen-secures-new-direct-to-consumer-business-facility-2017-06-05", "https://www.nasdaq.com/articles/rti-surgical-now-part-of-us-based-manufacturing-initiative-2017-06-05", "https://www.nasdaq.com/articles/align-technology-upgrades-itero-element-intraoral-scanners-2017-06-01", "https://www.nasdaq.com/articles/medtronic-starts-prodigy-study-on-respiratory-compromise-2017-06-01", "https://www.nasdaq.com/articles/becton-dickinson-at-52-week-high%3A-whats-driving-the-stock-2017-05-31", "https://www.nasdaq.com/articles/baxter-international-at-a-52-week-high-on-solid-product-line-2017-05-31", "https://www.nasdaq.com/articles/patterson-companies-grapples-with-multiple-issues%3A-dump-now-2017-06-02", "https://www.nasdaq.com/articles/masimo-masi-o3-regional-oximetry-device-gets-fda-nod-2017-05-31", "https://www.nasdaq.com/articles/labcorp-trades-down-on-weak-2017-view-reimbursement-woes-2017-05-31", "https://www.nasdaq.com/articles/boston-scientific-trades-up-on-strong-q1-amid-recall-issues-2017-05-30", "https://www.nasdaq.com/articles/idexx-laboratories-global-growth-solid-amid-currency-woes-2017-05-30", "https://www.nasdaq.com/articles/quintiles-ims-holdings-q-to-repurchase-10.6m-common-share-2017-05-30", "https://www.nasdaq.com/articles/nuvasive-aims-for-innovation-global-growth-amid-woes-2017-05-30", "https://www.nasdaq.com/articles/inogen-ingn-hits-a-52-week-high-on-solid-q1-upbeat-view-2017-05-30", "https://www.nasdaq.com/articles/intuitive-surgical-da-vinci-x-surgical-system-okayed-by-fda-2017-05-31", "https://www.nasdaq.com/articles/thermo-fisher-on-an-acquisition-spree-competition-rife-2017-05-30", "https://www.nasdaq.com/articles/myriad-genetics-gets-extended-coverage-for-prolaris-test-2017-05-29", "https://www.nasdaq.com/articles/patterson-companies-pdco-earnings-beat-estimates-in-q4-2017-05-26", "https://www.nasdaq.com/articles/veeva-systems-veev-beats-q1-earnings-revenues-estimates-2017-05-26", "https://www.nasdaq.com/articles/stryker-syk-at-52-week-high%3A-whats-driving-the-stock-2017-05-26", "https://www.nasdaq.com/articles/quest-diagnostics-hits-a-52-week-high-on-solid-prospects-2017-05-26", "https://www.nasdaq.com/articles/henry-schein-hsic-rides-on-global-growth-strategic-deals-2017-05-26", "https://www.nasdaq.com/articles/varian-medical-at-a-52-week-high%3A-whats-driving-the-stock-2017-05-30", "https://www.nasdaq.com/articles/boston-scientific-bsx-bt-study-on-asthma-results-positive-2017-05-25", "https://www.nasdaq.com/articles/varian-var-probeam-proton-therapy-system-now-in-thailand-2017-05-25", "https://www.nasdaq.com/articles/align-technology-rises-with-invisalign-smarttrack-patents-2017-05-25", "https://www.nasdaq.com/articles/medtronic-mdt-tops-q4-earnings-sales-on-balanced-growth-2017-05-25", "https://www.nasdaq.com/articles/bruker-corp-brkr-at-52-week-high%3A-whats-driving-the-stock-2017-05-23", "https://www.nasdaq.com/articles/intuitive-surgical-at-52-week-high%3A-whats-driving-the-stock-2017-05-22", "https://www.nasdaq.com/articles/quality-systems-professional-service-a-drag-competition-rife-2017-05-24", "https://www.nasdaq.com/articles/envision-evhc-acquires-gwinnett-emergency-specialists-2017-05-23", "https://www.nasdaq.com/articles/halyard-health-hyh-expands-corgrip-system-product-line-2017-05-23", "https://www.nasdaq.com/articles/hologic-holx-poised-on-balanced-growth-amid-currency-woes-2017-05-23", "https://www.nasdaq.com/articles/avoid-market-volatility-with-5-low-beta-stocks-2017-05-23", "https://www.nasdaq.com/articles/idexx-laboratories-idxx-raised-to-buy-on-solid-prospects-2017-05-23", "https://www.nasdaq.com/articles/bruker-corp-brkr-at-52-week-high%3A-whats-driving-the-stock-2017-05-23", "https://www.nasdaq.com/articles/intuitive-surgical-at-52-week-high%3A-whats-driving-the-stock-2017-05-22", "https://www.nasdaq.com/articles/quality-systems-professional-service-a-drag-competition-rife-2017-05-24", "https://www.nasdaq.com/articles/integra-lifesciences-hits-52-week-high-on-product-launches-2017-05-22", "https://www.nasdaq.com/articles/mckesson-mck-beats-earnings-estimate-in-q4-revenues-miss-2017-05-19", "https://www.nasdaq.com/articles/halyard-health-sustainable-solutions-ink-license-agreement-2017-05-19", "https://www.nasdaq.com/articles/hill-rom-impresses-with-q2-results-strategic-initiatives-2017-05-19", "https://www.nasdaq.com/articles/mazor-robotics-at-a-52-week-high%3A-whats-driving-the-stock-2017-05-19", "https://www.nasdaq.com/articles/exactech-exac-gets-fda-approval-for-exactechgps-application-2017-05-18", "https://www.nasdaq.com/articles/boston-scientifics-symetis-buyout-boosts-structural-heart-2017-05-18", "https://www.nasdaq.com/articles/quality-systems-qsii-beats-q4-earnings-issues-fy18-view-2017-05-22", "https://www.nasdaq.com/articles/halyard-health-announces-new-drainage-system-stock-down-2017-05-18", "https://www.nasdaq.com/articles/boston-scientific-hits-a-52-week-high-on-solid-prospects-2017-05-17", "https://www.nasdaq.com/articles/abbott-lab-well-poised-on-strong-epd-st.-jude-integration-2017-05-17", "https://www.nasdaq.com/articles/genomic-health-q1-results-weak-cancer-test-business-strong-2017-05-17", "https://www.nasdaq.com/articles/evolent-health-evh-prices-7m-follow-on-share-offering-2017-05-16", "https://www.nasdaq.com/articles/genomic-healths-ghdx-oncotype-dx-gps-test-data-positive-2017-05-16", "https://www.nasdaq.com/articles/teleflex-to-introduce-arrow-ac3-optimus-at-europcr-paris-2017-05-16", "https://www.nasdaq.com/articles/medtronics-mycarelink-data-on-older-patients-found-positive-2017-05-18", "https://www.nasdaq.com/articles/medtronic-icms-detect-high-rate-of-af-in-undiagnosed-patients-2017-05-15", "https://www.nasdaq.com/articles/cr-bard-bcr-hits-a-52-week-high%3A-whats-driving-the-stock-2017-05-15", "https://www.nasdaq.com/articles/varian-probeam-proton-system-gets-okayed-by-shonin-in-japan-2017-05-11", "https://www.nasdaq.com/articles/luminex-lmnx-tops-q1-earnings-revenue-guidance-raised-2017-05-02", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-25-chegg-surges-higher-2017-05-02", "https://www.nasdaq.com/articles/3-top-medical-instrument-companies-buy-2017-2017-04-04", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-ex-dividend-date-scheduled-march-22-2017-2017-03-21", "https://www.nasdaq.com/articles/thermo-fisher-tmo-to-buy-patheon-expand-in-biopharma-2017-05-16", "https://www.nasdaq.com/articles/luminex-lmnx-posts-loss-in-q4-revenues-miss-estimates-2017-02-07", "https://www.nasdaq.com/articles/should-you-sell-luminex-lmnx-before-earnings-2017-02-03", "https://www.nasdaq.com/articles/medical-product-stocks-earnings-on-feb-6%3A-hae-pahc-more-2017-02-03", "https://www.nasdaq.com/articles/luminex-projects-strong-q4-revenues-issues-2017-guidance-2017-01-11", "https://www.nasdaq.com/articles/luminex-lmnx-gets-fda-clearance-for-aries-gbs-assay-2017-01-05", "https://www.nasdaq.com/articles/luminex-awarded-rd-100-for-aries-systems-in-november-2016-12-06", "https://www.nasdaq.com/articles/luminex%3A-erasmus-assesses-aries-system-flu-a-b-rsv-2016-11-18", "https://www.nasdaq.com/articles/luminex-lmnx-down-4.4-since-earnings-report%3A-can-it-rebound-2017-03-09", "https://www.nasdaq.com/articles/medical-product-earnings-early-next-week%3A-cah-zbh-more-2016-10-28", "https://www.nasdaq.com/articles/should-you-buy-luminex-lmnx-ahead-of-earnings-2016-10-27", "https://www.nasdaq.com/articles/4-medical-device-stocks-on-a-bull-run-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/luminex-poised-on-pipeline-strength-system-sales-upbeat-2016-08-30", "https://www.nasdaq.com/articles/luminex-lmnx-receives-fda-clearance-for-xmap-assay-2016-08-15", "https://www.nasdaq.com/articles/luminex-lmnx-gets-fda-nod-for-assays-q2-earnings-beat-2016-08-03", "https://www.nasdaq.com/articles/luminex-lmnx-rallies-on-fda-nod-for-aries-m1-system-2016-07-07", "https://www.nasdaq.com/articles/luminex-lmnx-misses-q3-earnings-estimates-16-view-up-2016-11-03", "https://www.nasdaq.com/articles/luminex-well-poised-on-pipeline-strength-strategic-tie-ups-2016-06-27", "https://www.nasdaq.com/articles/increased-earnings-estimates-seen-for-luminex-lmnx%3A-can-it-move-higher-2016-06-02", "https://www.nasdaq.com/articles/luminexs-aries-flu-a-b-rsv-assay-now-ce-ivd-marked-2016-06-02", "https://www.nasdaq.com/articles/midday-update-us-stocks-treading-water-amid-fed-comments-2016-05-23", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-slightly-higher-arbor-pharmaceuticals-buy-xenoport", "https://www.nasdaq.com/articles/close-update-stocks-trade-lower-traders-eye-fed-clues-rate-hikes-2016-05-23", "https://www.nasdaq.com/articles/health-care-sector-update-05232016-nsphrnptchrs-2016-05-23", "https://www.nasdaq.com/articles/luminex-closes-nanosphere-buyout-maintains-fy16-view-2016-07-04", "https://www.nasdaq.com/articles/luminex-well-poised-on-pipeline-strength-strategic-tie-ups-2016-06-27", "https://www.nasdaq.com/articles/increased-earnings-estimates-seen-for-luminex-lmnx%3A-can-it-move-higher-2016-06-02", "https://www.nasdaq.com/articles/luminexs-aries-flu-a-b-rsv-assay-now-ce-ivd-marked-2016-06-02", "https://www.nasdaq.com/articles/midday-update-us-stocks-treading-water-amid-fed-comments-2016-05-23", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-slightly-higher-arbor-pharmaceuticals-buy-xenoport", "https://www.nasdaq.com/articles/close-update-stocks-trade-lower-traders-eye-fed-clues-rate-hikes-2016-05-23", "https://www.nasdaq.com/articles/health-care-sector-update-05232016-nsphrnptchrs-2016-05-23", "https://www.nasdaq.com/articles/luminex-closes-nanosphere-buyout-maintains-fy16-view-2016-07-04", "https://www.nasdaq.com/articles/midday-update-wall-street-buoyed-gains-apple-and-oil-2016-05-16", "https://www.nasdaq.com/articles/mid-day-market-update-nanosphere-jumps-following-luminex-deal-breitburn-energy-partners", "https://www.nasdaq.com/articles/trovagene-plunges-on-ceo-and-cfo-dismissal-files-suit-2016-03-29", "https://www.nasdaq.com/articles/varian-opens-service-center-in-wuxi-expands-in-china-2016-03-23", "https://www.nasdaq.com/articles/luminexs-lmnx-aries-now-ce-ivd-marked-shares-fall-2016-03-22", "https://www.nasdaq.com/articles/mazor-robotics-renaissance-system-ordered-in-new-jersey-2016-03-18", "https://www.nasdaq.com/articles/intuitive-surgical%3A-fda-oks-da-vinci-xi-single-site-instruments-2016-03-17", "https://www.nasdaq.com/articles/luminex-lmnx-beats-q1-earnings-revenues-guides-up-2016-05-05", "https://www.nasdaq.com/articles/intuitive-surgical%3A-fda-okays-endowrist-stapler-instruments-2016-03-16", "https://www.nasdaq.com/articles/inogen-q4-earnings-crushes-estimates-fy16-view-impressive-2016-03-15", "https://www.nasdaq.com/articles/dexcom-launches-g5-platinum-cgm-app-on-apple-watch-2016-03-15", "https://www.nasdaq.com/articles/greatbatch-completes-qig-spin-off-nuvectra-begins-trading-2016-03-15", "https://www.nasdaq.com/articles/cantel-medical-up-on-q2-earnings-beat-sales-improvement-2016-03-14", "https://www.nasdaq.com/articles/intuitive-surgical-isrg-at-52-week-high-on-solid-portfolio-2016-03-14", "https://www.nasdaq.com/articles/inogen-ingn-q4-earnings%3A-a-surprise-in-the-cards-2016-03-11", "https://www.nasdaq.com/articles/alere-alr-handed-subpoena-by-us-doj-shares-plunge-2016-03-16", "https://www.nasdaq.com/articles/intuitive-surgical%3A-fda-okays-endowrist-stapler-instruments-2016-03-16", "https://www.nasdaq.com/articles/inogen-q4-earnings-crushes-estimates-fy16-view-impressive-2016-03-15", "https://www.nasdaq.com/articles/dexcom-launches-g5-platinum-cgm-app-on-apple-watch-2016-03-15", "https://www.nasdaq.com/articles/greatbatch-completes-qig-spin-off-nuvectra-begins-trading-2016-03-15", "https://www.nasdaq.com/articles/cantel-medical-up-on-q2-earnings-beat-sales-improvement-2016-03-14", "https://www.nasdaq.com/articles/intuitive-surgical-isrg-at-52-week-high-on-solid-portfolio-2016-03-14", "https://www.nasdaq.com/articles/becton-dickinson-to-roll-out-bd-totalys-system-in-us-2016-03-08", "https://www.nasdaq.com/articles/trovagene-trov-falls-on-wider-than-expected-q4-loss-2016-03-11", "https://www.nasdaq.com/articles/cooper-companies-coo-beats-on-q1-earnings-and-revenues-2016-03-04", "https://www.nasdaq.com/articles/thermo-fisher-tmo-tops-q4-numbers-amid-currency-woes-2016-03-04", "https://www.nasdaq.com/articles/weight-watchers-gains-on-publicity-pact-with-oprah-winfrey-2016-03-04", "https://www.nasdaq.com/articles/natus-medical%3A-neuroquest-buy-boosts-in-home-aeeg-suite-2016-03-04", "https://www.nasdaq.com/articles/cantel-medical-acquisition-suite-accretive-adds-namsa-unit-2016-03-03", "https://www.nasdaq.com/articles/akers-receives-order-for-rapid-assays-in-china-shares-rise-2016-03-03", "https://www.nasdaq.com/articles/trovagene-trov-inks-deal-with-multiplan-shares-rally-2016-03-02", "https://www.nasdaq.com/articles/cogentix-medical-q3-loss-narrower-than-expected-sales-top-2016-03-07", "https://www.nasdaq.com/articles/dentsply-sirona-dental-systems-unite-form-new-entity-2016-03-01", "https://www.nasdaq.com/articles/evolent-q4-loss-narrower-than-expected-revenues-beat-2016-02-29", "https://www.nasdaq.com/articles/pra-health-prah-q4-earnings-top-estimates-revenues-up-2016-02-29", "https://www.nasdaq.com/articles/weight-watchers-posts-q4-loss-beats-revenue-estimate-2016-02-26", "https://www.nasdaq.com/articles/fresenius-medical-misses-on-q4-earnings-and-revenues-2016-02-25", "https://www.nasdaq.com/articles/adeptus-health-q4-earnings-revenues-up-y-y-shares-rise-2016-02-25", "https://www.nasdaq.com/articles/masimo-masi-misses-q4-earnings-fy16-view-disappoints-2016-02-24", "https://www.nasdaq.com/articles/nevro-q4-loss-narrower-than-expected-revenues-in-line-2016-03-01", "https://www.nasdaq.com/articles/luminex-receives-regulatory-approval-for-aries-in-canada-2016-02-23", "https://www.nasdaq.com/articles/trovagene-trov-up-on-fortified-provider-network-deal-2016-02-23", "https://www.nasdaq.com/articles/masimos-specialized-root-monitoring-gets-fda-approval-2016-02-22", "https://www.nasdaq.com/articles/gnc-holdings%3A-overseas-business-strong-competition-rife-2016-02-22", "https://www.nasdaq.com/articles/mazor-robotics-q4-loss-narrows-revenues-improve-y-y-2016-02-19", "https://www.nasdaq.com/articles/stryker-eyes-physio-control-aims-to-enhance-product-suite-2016-02-18", "https://www.nasdaq.com/articles/rti-surgical-rtix-beats-on-q4-earnings-and-revenues-2016-02-17", "https://www.nasdaq.com/articles/icon-iclr-beats-q4-earnings-misses-revenue-estimates-2016-02-24", "https://www.nasdaq.com/articles/align-technology%3A-invisalign-grows-in-q4-currency-bothers-2016-02-17", "https://www.nasdaq.com/articles/qiagen-posts-positive-data-for-next-gen-tb-diagnostic-assay-2016-02-17", "https://www.nasdaq.com/articles/cryolife-cry-beats-on-q4-earnings-revenues-up-y-y-2016-02-16", "https://www.nasdaq.com/articles/masimos-ram-technology-proven-to-reduce-alarm-events-2016-02-15", "https://www.nasdaq.com/articles/gnc-holdings-beats-q4-earnings-by-a-penny-hikes-dividend-2016-02-12", "https://www.nasdaq.com/articles/invacare-ivc-q4-loss-narrower-than-estimate-sales-miss-2016-02-12", "https://www.nasdaq.com/articles/henry-schein-rides-high-on-acquisitions-amid-currency-woes-2016-02-12", "https://www.nasdaq.com/articles/the-ensign-group-lags-q4-earnings-revenues-view-intact-2016-02-11", "https://www.nasdaq.com/articles/medidata-mdso-q4-earnings-top-revenues-miss-up-y-y-2016-02-11", "https://www.nasdaq.com/articles/fluidigm-q4-loss-narrower-than-expected-revenues-fall-y-y-2016-02-10", "https://www.nasdaq.com/articles/henry-schein-hsic-tops-q4-earnings-on-strong-revenues-2016-02-10", "https://www.nasdaq.com/articles/cynosure-cyno-up-on-q4-earnings-and-revenue-beat-2016-02-10", "https://www.nasdaq.com/articles/st.-jude-medicals-optis-mobile-system-in-japan-europe-2016-02-10", "https://www.nasdaq.com/articles/steris-tops-q3-earnings-synergy-health-integration-strong-2016-02-10", "https://www.nasdaq.com/articles/angiodynamics%3A-health-canada-okays-celerity-with-navigation-2016-02-09", "https://www.nasdaq.com/articles/the-ensign-group-lags-q4-earnings-revenues-view-intact-2016-02-11", "https://www.nasdaq.com/articles/luminex-lmnx-in-focus%3A-stock-adds-5.1-in-session-2016-02-03", "https://www.nasdaq.com/articles/luminex-lmnx-outshines-q4-earnings-revenues-in-line-2016-02-02", "https://www.nasdaq.com/articles/health-care-sector-update-02022016-lmnxhnsncbyl-2016-02-02", "https://www.nasdaq.com/articles/luminex-lmnx-receives-fda-approval-for-nxtag-rpp-2015-12-21", "https://www.nasdaq.com/articles/affymetrix-affx-inks-partnership-with-reveal-biosciences-2015-12-07", "https://www.nasdaq.com/articles/best-stocks-gene-sequencing-2015-06-18", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-luminex-lmnx-2015-11-05", "https://www.nasdaq.com/articles/luminex-lmnx-tops-q3-earnings-sales-pipeline-strong-2015-11-03", "https://www.nasdaq.com/articles/affymetrix-beats-q3-earnings-lags-sales-margins-view-up-2015-10-29", "https://www.nasdaq.com/articles/luminex-lmnx-signs-distribution-deal-with-bio-techne-2015-10-22", "https://www.nasdaq.com/articles/luminex-lmnx-shares-rally-on-fda-approval-for-aries-2015-10-08", "https://www.nasdaq.com/articles/luminex-lmnx-tops-q2-earnings-revenues-pipeline-strong-analyst-blog-2015-08-04", "https://www.nasdaq.com/articles/cepheids-cphd-xpert-hiv-1-qual-test-gets-ce-ivd-mark-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/qiagen-grows-on-molecular-diagnostics-americas-disappoint-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/3-big-healthcare-trends-wall-street-overlooking-2015-06-14", "https://www.nasdaq.com/articles/luminex-commences-clinical-trials-for-aries-gbs-assay-analyst-blog-2015-06-09", "https://www.nasdaq.com/articles/surging-earnings-estimates-signal-good-news-for-luminex-lmnx-tale-of-the-tape-2015-06-01", "https://www.nasdaq.com/articles/luminex-tops-q1-earnings-revenues-maintains-fy15-view-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/luminex-rallies-on-positive-aries-clinical-trial-update-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/thermo-fisher-q1-earnings-top-revenues-lag-estimates-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/cepheids-cphd-xpert-hiv-1-qual-test-gets-ce-ivd-mark-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/qiagen-grows-on-molecular-diagnostics-americas-disappoint-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/cyberonics-sorin-%242.7b-deal-gets-us-antitrust-go-ahead-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/heartware-gets-vad-distribution-approval-from-health-canada-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/intuitve-surgicals-product-line-strong-hits-52-week-high-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/dexcom-hits-52-week-high-on-q4-results-estimate-revision-analyst-blog-2015-04-10", "https://www.nasdaq.com/articles/luminex-lmnx-launches-nxtag-rpp-for-respiratory-testing-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/4-good-investments-for-good-friday-analyst-blog-2015-04-02", "https://www.nasdaq.com/articles/luminex-lmnx-commences-clinical-trials-for-aries-system-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/inogen-gains-despite-further-delay-in-form-10-k-filing-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/perkinelmer%3A-52-week-high-on-solid-q4-positive-2015-view-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/fresenius-medical%3A-52-week-high-on-solid-q4-bright-view-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/the-cooper-companies-seeks-license-option-from-ep-global-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/alere-alr-touches-52-week-high-on-portfolio-expansion-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/accuray-expands-internationally-inks-sales-deal-in-canada-analyst-blog-2015-03-11", "https://www.nasdaq.com/articles/icon-raised-to-strong-buy-on-stellar-q4-strategic-acquisition-analyst-blog-2015-03-11", "https://www.nasdaq.com/articles/air-methods-airm-q4-earnings-top-estimates-surge-y-y-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/the-cooper-companies-hits-52-week-high-on-earnings-beat-analyst-blog-2015-03-09", "https://www.nasdaq.com/articles/heartware-international-posts-q4-loss-mvad-holds-promise-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/the-cooper-companies-tops-q1-earnings-lags-revenues-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/hologic-holx-continues-to-impress%3A-should-you-invest-now-analyst-blog-2015-03-06", "https://www.nasdaq.com/articles/accuray-cyberknife-m6-with-incise-mlc-treats-first-patient-analyst-blog-2015-03-05", "https://www.nasdaq.com/articles/nxstage-medical-nxtm-q4-loss-narrower-than-expected-analyst-blog-2015-03-04", "https://www.nasdaq.com/articles/icon-iclr-posts-stellar-q4-earnings-revenues-rise-y-y-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/air-methods-airm-q4-earnings-top-estimates-surge-y-y-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/the-cooper-companies-hits-52-week-high-on-earnings-beat-analyst-blog-2015-03-09", "https://www.nasdaq.com/articles/omnicare-ocr-q4-earnings-sales-top-estimates-rise-y-y-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/globus-medical-gmed-beats-on-q4-earnings-sales-in-line-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/cyberonics-tops-q3-earnings-vitaria-system-gets-ce-mark-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/allscripts-mdrx-tops-q4-earnings-by-a-penny-revenues-lag-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/fresenius-medical-care-fms-tops-q4-earnings-revenues-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/dexcom-reports-earnings-in-q4-top-line-surges-y-y-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/healthways-beats-q4-earnings-on-strong-top-line-growth-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/merit-medical-mmsi-q4-earnings-sales-top-estimates-up-y-y-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/greatbatch-q4-earnings-top-on-solid-margins-revenues-lag-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/adeptus-health-q4-earnings-miss-revenues-in-line-up-y-y-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/t2-biosystems-ttoo-crumbles%3A-stock-falls-by-5.8-tale-of-the-tape-2015-02-24", "https://www.nasdaq.com/articles/teleflex-hits-52-week-high-on-strong-q4-strategic-deals-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/heartware-recalls-old-ventricular-assist-system-controllers-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/teleflex-tfx-q4-earnings-revenues-top-estimates-up-y-y-analyst-blog-2015-02-23", "https://www.nasdaq.com/articles/exactech-exac-q4-earnings-top-revenues-miss-estimates-analyst-blog-2015-02-19", "https://www.nasdaq.com/articles/merit-medical-mmsi-q4-earnings-sales-top-estimates-up-y-y-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/greatbatch-q4-earnings-top-on-solid-margins-revenues-lag-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/adeptus-health-q4-earnings-miss-revenues-in-line-up-y-y-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/t2-biosystems-ttoo-crumbles%3A-stock-falls-by-5.8-tale-of-the-tape-2015-02-24", "https://www.nasdaq.com/articles/cryolife-cry-down-as-q4-earnings-fall-revenues-rise-y-y-analyst-blog-2015-02-18", "https://www.nasdaq.com/articles/abiomed-hits-52-week-high-on-solid-q3-impella-rp-approval-analyst-blog-2015-02-17", "https://www.nasdaq.com/articles/cepheids-tb-test-wins-fda-clearance-for-expanded-use-analyst-blog-2015-02-16", "https://www.nasdaq.com/articles/varian-medicals-probeam-proton-therapy-now-in-denmark-analyst-blog-2015-02-13", "https://www.nasdaq.com/articles/patterson-companies-pdco-lags-q3-earnings-revenues-analyst-blog-2015-02-19", "https://www.nasdaq.com/articles/thoratec-beats-q4-earnings-and-revenues-shares-rise-analyst-blog-2015-02-11", "https://www.nasdaq.com/articles/luminex-lmnx-enters-oversold-territory-tale-of-the-tape-2015-02-10", "https://www.nasdaq.com/articles/fluidigm-q4-loss-narrower-than-expected-revenues-up-y-y-analyst-blog-2015-02-09", "https://www.nasdaq.com/articles/accurays-tomotherapy-gains-traction-in-latin-america-revised-analyst-blog-2015-02-09", "https://www.nasdaq.com/articles/mettler-toledo-tops-earnings-revenues-on-margin-strength-analyst-blog-2015-02-06", "https://www.nasdaq.com/articles/accurays-tomotherapy-gains-traction-in-latin-america-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/edwards-lifesciences-tops-q4-earnings-sales-alters-view-analyst-blog-2015-02-04", "https://www.nasdaq.com/articles/cepheid-strong-on-q4-global-expansion-currency-woes-stay-analyst-blog-2015-02-12", "https://www.nasdaq.com/articles/luminex-lmnx%3A-strong-buy-on-solid-q4-pipeline-strength-analyst-blog-2015-02-04", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-autonation-profit-beats-views-2015-02-03", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-top-revenues-meet-estimates-analyst-blog-2015-02-03", "https://www.nasdaq.com/articles/health-care-sector-update-02032015-lmnxesprontx-2015-02-03", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-biotechnology-stocks-2015-02-03", "https://www.nasdaq.com/articles/why-luminex-corporation-shares-got-slashed-2015-02-03", "https://www.nasdaq.com/articles/luminex-gets-health-canada-approval-for-genotyping-assay-analyst-blog-2015-02-02", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2015-02-04", "https://www.nasdaq.com/articles/fluidigm-fldm-upgraded-to-strong-buy-on-pipeline-strength-analyst-blog-2014-12-29", "https://www.nasdaq.com/articles/luminex-grows-on-product-launches-strategic-partnerships-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/luminex-lmnx-upgraded-to-strong-buy-on-impressive-q3-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-pfizer-profit-tops-street-view-2014-10-28", "https://www.nasdaq.com/articles/mid-day-market-update-integrated-device-technology-jumps-upbeat-earnings-twitter-shares", "https://www.nasdaq.com/articles/luminex-tops-q3-earnings-revenues-in-line-outlook-weak-analyst-blog-2014-10-28", "https://www.nasdaq.com/articles/luminex-lmnx-crumbles%3A-stock-falls-by-7.5-tale-of-the-tape-2014-10-16", "https://www.nasdaq.com/articles/luminex-lmnx-likely-to-miss-earnings-estimates-in-q4-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/fluidigm-fldm-upgraded-to-strong-buy-on-pipeline-strength-analyst-blog-2014-12-29", "https://www.nasdaq.com/articles/luminex-grows-on-product-launches-strategic-partnerships-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/luminex-lmnx-upgraded-to-strong-buy-on-impressive-q3-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-pfizer-profit-tops-street-view-2014-10-28", "https://www.nasdaq.com/articles/thoratec-begins-heartmate-iii-ce-mark-clinical-trial-analyst-blog-2014-06-30", "https://www.nasdaq.com/articles/cvs-forms-pharmacy-care-alliance-analyst-blog-2014-06-30", "https://www.nasdaq.com/articles/sirona-dental-hits-new-52-week-high-analyst-blog-2014-06-27", "https://www.nasdaq.com/articles/luminex-trends-up-hits-52-week-high-on-strong-q2-results-analyst-blog-2014-10-09", "https://www.nasdaq.com/articles/sluggish-chinese-market-continues-to-drag-down-mindray-medical-analyst-blog-2014-06-27", "https://www.nasdaq.com/articles/intuitive-surgicals-new-da-vinci-robot-gets-ce-mark-analyst-blog-2014-06-26", "https://www.nasdaq.com/articles/hologics-3d-mammography-improves-breast-cancer-screening-analyst-blog-2014-06-25", "https://www.nasdaq.com/articles/angiodynamics-celerity-system-wins-fda-nod-for-picc-analyst-blog-2014-06-19", "https://www.nasdaq.com/articles/techne-corporation-to-acquire-proteinsimple-analyst-blog-2014-06-18", "https://www.nasdaq.com/articles/edwards-lifesciences-aortic-heart-valve-gets-fda-approval-analyst-blog-2014-06-17", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/brukers-maldi-biotyper-approved-for-biochemical-testing-in-china-analyst-blog-2014-06-27", "https://www.nasdaq.com/articles/varian-medical-systems-prime-healthcare-ink-technology-deal-analyst-blog-2014-06-16", "https://www.nasdaq.com/articles/masimo-gains-on-positive-pvi-sphb-study-data-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/surging-earnings-estimates-signal-good-news-for-luminex-lmnx-tale-of-the-tape-2014-05-14", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-29-1", "https://www.nasdaq.com/articles/luminex-1q-earnings-rise-50-beat-ests-analyst-blog-2014-04-29", "https://www.nasdaq.com/articles/mid-sized-gains-healthcare-stocks-luminex-jumps-more-20-after-dispatching-q1-analyst", "https://www.nasdaq.com/articles/balanced-view-of-luminex-corporation-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/dexcom-collaborates-with-insulet-corporation-analyst-blog-2014-06-16", "https://www.nasdaq.com/articles/varian-medical-systems-prime-healthcare-ink-technology-deal-analyst-blog-2014-06-16", "https://www.nasdaq.com/articles/masimo-gains-on-positive-pvi-sphb-study-data-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/surging-earnings-estimates-signal-good-news-for-luminex-lmnx-tale-of-the-tape-2014-05-14", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-29-1", "https://www.nasdaq.com/articles/luminex-1q-earnings-rise-50-beat-ests-analyst-blog-2014-04-29", "https://www.nasdaq.com/articles/mid-sized-gains-healthcare-stocks-luminex-jumps-more-20-after-dispatching-q1-analyst", "https://www.nasdaq.com/articles/balanced-view-of-luminex-corporation-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/breakthrough-for-luminexs-xmap-technology-analyst-blog-2014-03-19", "https://www.nasdaq.com/articles/luminex-earnings-beat-but-fall-y-y-shares-down-analyst-blog-2014-02-05", "https://www.nasdaq.com/articles/luminex-remains-neutral-analyst-blog-2013-12-02", "https://www.nasdaq.com/articles/luminex-corporation-lmnx-new-analyst-report-zacks-equity-research-zacks-equity-research", "https://www.nasdaq.com/articles/luminex-lags-on-eps-and-revs-guides-down-analyst-blog-2013-11-05", "https://www.nasdaq.com/articles/ango-launches-bioflo-picc-trial-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/angiodynamics-stays-neutral-analyst-blog-2013-10-03", "https://www.nasdaq.com/articles/commit-buy-luminex-corp-15-earn-102-annualized-using-options-2014-04-11", "https://www.nasdaq.com/articles/angiodynamics-restructures-debt-analyst-blog-2013-09-26", "https://www.nasdaq.com/articles/luminex-assay-cleared-in-u.s.-and-europe-analyst-blog-2013-09-24", "https://www.nasdaq.com/articles/arrow-brand-expansion-may-boost-teleflex-analyst-blog-2013-09-23", "https://www.nasdaq.com/articles/bruker-unveils-multimodal-animal-bed-analyst-blog-2013-09-20", "https://www.nasdaq.com/articles/health-canada-approves-angos-celerity-system-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/bruker-to-acquire-prairie-technologies-analyst-blog-2013-09-18", "https://www.nasdaq.com/articles/abiomed-reiterated-at-neutral-analyst-blog-2013-09-12", "https://www.nasdaq.com/articles/dexcom-retained-at-neutral-analyst-blog-2013-09-30", "https://www.nasdaq.com/articles/masimo-wins-new-u.s.-client-analyst-blog-2013-09-10", "https://www.nasdaq.com/articles/cepheids-tb-test-okd-by-fda-analyst-blog-2013-08-29", "https://www.nasdaq.com/articles/accuray-posts-narrower-than-expected-loss-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/varian-helps-upgrade-nhs-hospitals-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/abiomed-wins-federal-contract-analyst-blog-2013-08-27", "https://www.nasdaq.com/articles/cyberonics-tops-earnings-estimates-analyst-blog-2013-08-23", "https://www.nasdaq.com/articles/hologic-grows-skeletal-health-range-analyst-blog-2013-08-15", "https://www.nasdaq.com/articles/teleflex-promotes-lung-isolation-product-analyst-blog-2013-09-10", "https://www.nasdaq.com/articles/insiders-buy-stock-philip-morris-international-and-luminex-2013-08-07", "https://www.nasdaq.com/articles/market-wrap-tuesday-july-30-technology-sector-rises-basic-materials-hit-hard-2013-07-30", "https://www.nasdaq.com/articles/good-news-for-luminex-analyst-blog-2013-07-23", "https://www.nasdaq.com/articles/luminex-collaborates-with-nmtc-analyst-blog-2013-06-14", "https://www.nasdaq.com/articles/luminex-and-merck-kgaa-extend-ties-analyst-blog-2013-05-31", "https://www.nasdaq.com/articles/insider-trading-tesla-motors-sees-sale-while-mosys-ceo-buys-shares-2013-05-21", "https://www.nasdaq.com/articles/bsx-and-abmd-highlight-increased-insider-buying-medical-technology-sector-2013-05-14", "https://www.nasdaq.com/articles/luminex-beats-1q-earnings-est.-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/fda-nod-for-luminex-offering-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/merck-luminex-alzheimers-collaboration-analyst-blog-2013-03-19", "https://www.nasdaq.com/articles/luminex-beats-eps-profits-up-analyst-blog-2013-02-05", "https://www.nasdaq.com/articles/luminex-wins-fda-clearance-analyst-blog-2013-01-16", "https://www.nasdaq.com/articles/retaining-luminex-at-neutral-analyst-blog-2012-02-10", "https://www.nasdaq.com/articles/luminex-beats-on-assay-boost-analyst-blog-2012-02-07", "https://www.nasdaq.com/articles/luminex-wins-technology-award-analyst-blog-2012-09-07"], "Content": []}